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2 SUMMARY
2 SUMMARY
Regeneration is a process that renews damaged or lost cells, tissues, or even of entire body structures, and
is a phenomenon which is widespread in the animal kingdom. Urodeles such as newts and salamanders have
a remarkable regeneration ability. They can regenerate organs such as gills, lower jaws, retina, appendages
like fore- and hind limbs, and also the tail including the spinal cord.
The regeneration process requires the use of resident stem cells or somatic cells, which have to be repro-
grammed. In both cases the reprogrammed cells are less differentiated, meaning the cell would have the
ability to form any kind of fetal or adult cell which rose from the three different germ layers, the ectoderm,
mesoderm and endoderm.
Artificial reprogramming of differentiated mammalian somatic cell had been reported previously. It was
shown that four pluripotency factors, OCT4 (also called POU5f1), SOX2, c-MYC and KLF4 are sufficient
to generate an induced pluripotent stem (iPS) cell. It has been shown that some of these factors are also
involved in regenerating processes. In newt limb and lens tissue, Sox2, c-Myc and Klf4 mRNA levels were
upregulated in the beginning of blastema formation when compared to non-amputated tissue. Oct4 mRNA
however, was not detected. During xenopus tail regeneration, Sox2 and c-Myc were expressed, while the
xenopus Pou homologs Pou25, Pou60, Pou79, Pou91 were not detected. In regenerating zebrafish fin tissue,
Sox2, Pou2, c-Myc and Klf4 mRNA were not upregulated.
The mammalian transcription factor OCT4, a class V POU protein, is responsible in maintaining pluripotency
in gastrula stage embryos. It was reported that mouse OCT4 is also expressed in the caudal node of embryos
having 16 somites. It is further known that progenitors exist in mouse tailbud, which give rise to neural and
mesodermal cell lineage. This suggests that the OCT4 expressing cells in caudal node might be a stem cell
reservoir.
Oct4 was detected in axolotl during embryonic development, and prior to my work we found Oct4 when
screening the axolotl blastema cDNA library. In addition, we also identified Pou2, another class V POU
gene. Phylogenetic analysis showed a clear distinction of both genes in the axolotl. We determined the
mRNA pattern of Pou2 during embryogenesis and compared it to Oct4 mRNA and protein. Both genes are
expressed in the primordial germ cells and the pluripotent animal cap region of the embryo. Apart from this
similarity, both genes have a different expression pattern in the embryo.
We are interested in the involvement of OCT4, POU2, as well as the transcription factor SOX2 in regenerating
axolotl spinal cord. We asked whether the cellular pluripotent character conferred by POU factors is limited
to mammals or if it is an ancient characteristic of lower vertebrates. To answer the question we performed
in vitro and in vivo studies. Hence this thesis is separated into two chapter.
By in vitro studies we investigated the pluripotent PouV orthologs from different species. Therefore, we
performed reprogramming experiments using mouse or human fibroblasts and transduced them with axolotl
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Oct4 or Pou2, in combination with human or axolotl Sox2, c-Myc and/or Klf4. The generated iPS cells
with the different sets of factors had similar endogenous pluripotency gene expression profiles to embryonic
stem cells. Further, iPS cells expressed the pluripotency markers like OCT4, NANOG, SSEA4, TRA1-60
and TRA1-81. Another evaluation of the iPS cells was the formation of embryoid bodies. Immunouorescence
staining showed that tissue from all three germ layers was formed after induction. We observed a positive
staining for the endoderm marker α-FEROPROTEIN, the mesoderm marker α-SMOOTH MUSCLE ACTIN
and the ectoderm marker βIII TUBULIN in the generated cells. This indicated that the iPS cells generated
using axolotl Oct4 and Sox2 in combination with mammalian Klf4 and with or without c-Myc, as well as
iPS cell generated with axolotl Pou2 and mammalian Sox2 and Klf4 and with or without c-Myc have a
pluripotent potential. In addition, the axolotl factors are able to form heterodimers with the mammalian
proteins. Furthermore, we compared the reprogramming ability with POU factors from mouse, human,
zebrash, medaka and xenopus. We showed that xenopus Pou91, as the only non-mammalian example, is
nearly as efficient as mouse and human Oct4 cDNAs in inducing GFP expressing cells. Also axolotl Pou2,
axolotl Oct4 and medaka Pou2 showed reprogramming character however at a much lower efficiency. In
contrast, zebrash Pou2 is not able to establish iPS cells. This indicates that a reprogramming ability to a
pluripotent cell state is an ancient trait of Pou2 and Oct4 homologs.
By in vivo studies we investigated the role of Oct4, Pou2 and Sox2 gene expression in regenerating spinal
cord tissue. Performed in situ hybridizations and antibody staining studies in the regenerating spinal cord
showed that Oct4, Pou2 and Sox2 were expressed during spinal cord regeneration.
Knockdown experiments in regenerating spinal cord using morpholino showed that Pou2-morpholino does
not have an effect. In contrast, SOX2 was required for spinal cord regeneration but to a lesser extent, than
OCT4, which decreased the regenerated length signicantly compared to control. Even though, with Sox2-
morpholino we did not observe the phenotype as a significantly shorter regenerated spinal cord, about 45%
of SOX2 knocked down cells were not cycling and proliferating anymore. This indicates that axolotl SOX2
has an effect in regeneration.
Therefore we wanted to know whether spinal cord cells would also have a pluripotent character in vivo and
form other tissue types. Regenerating cells of the spinal cord are only able to form the same cell type and thus
they keep their cell memory. However, when we performed transplantations of OCT4/SOX2 expressing spinal
cord cells into somite stage embryos, we could show the formation of muscle cells. This shows that the spinal
cord cells have the potential to change their fate in an embryonic context, where the normal environment of
spinal cord has changed. However, our data do not indicate whether muscle is formed directly from the spinal
cord or whether spinal cord cells fuse to developmental myoblasts, a cell type of embryonic progenitors, which
give rise to muscle cells. To clearly state whether regenerating OCT4/SOX2 expressing spinal cord cells are
pluripotent we have to perform OCT4 knock down in spinal cord and transplant these less proliferating cells
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into embryos, observing their cell fate.
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BF ...................... Brightfield
BrdU ...................... 5-bromo-2-deoxyuridine
BSA ...................... Bovine serum albumin
CNS ...................... Central nervous system
CV ...................... Column volumes
DF ...................... Darkfield
DNA ...................... Deoxyribonucleic acid
dpa ...................... Days post amputation
EGFP ...................... Enhanced green fluorescence protein
ES cells ...................... Embryonic stem cells
EST ...................... Expressed sequence tag
FACS ...................... Fluorescence-activated cell sorting
FGF ...................... Fibroblast growth factor
FITC ...................... Fluorescein isothiocyanate
GFP ...................... Green fluorescent protein
GST ...................... Glutathione S-transferase
hES cells ...................... Human embryonic stem cells
hFib ...................... Human fibroblasts
HS-AMEM ...................... High serum - Amphibian MEM - A1 cell culture medium
iPS cells ...................... Induced pluripotent stem cells
IPTG ...................... Isopropyl-β-D-thiogalactopyranosid
KLF4 ...................... Krueppel-like factor 4 transcription factor
MBP ...................... Maltose binding protein
MEF ...................... Mouse embryonic fibroblasts
mES cells ...................... Mouse embryonic stem cells
MHC ...................... Myosin heavy chains
N-M ...................... Progenitor cells for neural and mesodermal (N-M) lineages in the tailbud
c-MYC ...................... Transcription factor
NA ...................... Numerical aperture
NANOG ...................... Homeodomain containing transcription factor
OCT4 ...................... Octamer binding transcription factor 4
PBS ...................... Phosphate-Buffered Saline
PCR ...................... Polymerase chain reaction
PEC ...................... Pigment epithelial cells
qRT-PCR ...................... Quantitative real time polymerase chain reaction
RNA ...................... Ribonucleic acid
RT ...................... Room temperature
SOX2 ...................... SRY (sex determining region Y)-box 2 transcription factor
SSEA ...................... Stage specific embryonic antigen
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In this thesis I am going to talk about class V POU factors. There is an alternative nomenclature for Pou
orthologs across the literature. In this study the xenopus factors are named as POU25, POU60 and POU91.
The factor in medaka, the zebrafish and the chicken is named as POU2. Human, mouse and lizard factors
are termed as OCT4, and the two different factors in axolotl as OCT4 and POU2.
5.1 Regeneration is a natural phenomenon in a variety of species
Regeneration is defined as a process of renewal of damaged or lost cells, of tissue or even of entire body parts.
It is a phenomenon that is widespread but not uniformly represented in the animal kingdom. Regenerative
strategies involve rearranging of pre-exsisting tissue, utilization of adult stem cells, as well as dedifferentiation
and transdifferentiation of cells (see chapter 5.2). All these strategies can act in different tissues of the same
animal (Alvarado and Tsonis, 2006).
The birth on experimental biology in regeneration dates back to the 17th century when Abraham Trembley
performed the first experiments on Hydra, a prominent species regenerating lost body structures (Lenhoff
and Lenhoff, 1986).
While whole body regeneration can take place from a small amount of cells in Hydra or planaria, the regen-
eration in mammals is restricted. Mammals are able to regenerate adult liver, depending on the dimension
of the damage (Yoshizato:2007p231, Hata:2007p230), intestinal-tract epithelium, skin and muscle cells and
even digit tips of infants, if the amputation is distal of the first phalange and the wound not covered with
epithelium (Stevenson, 1992; Han et al., 2008; Yoshizato, 2007; Hata et al., 2007). Other injured tissue can
be replaced by connective tissue including scar formation and thus has differences and loss in function and
structure compared to the original.
Urodeles such as newts and salamanders keep their remarkable regeneration capacity also as adult. Anurans
like toads and frogs on the other hand lose their capacity in metamorphosis (for review see Tanaka and Ferretti
(2009)). The highest vertebrates and thus, evolutionary the closest relative to human that have regenerative
abilities are newts and salamanders. They can regenerate organs along the primary body axis like the tail
including the spinal cord, gills, lower jaws, retina and even partially the heart but also appendages like fore-
and hind limbs (Tsonis (2000), reviewed in Brockes and Kumar (2002)).
In the past decades the development of novel molecular biological tools enabled research on regenerative
aspects and became more interesting. To establish therapeutic treatments to restore human tissue or entire
organs at some point in the future it became important to understand the basic concept of the regeneration
mechanism. Thus, various animals are necessary model organisms to study regeneration.
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5.2 The source of stem cells
Regeneration requires the rearrangement of cells from pre-existing tissue, either by utilizing resident stem
cells, or through cell dedifferentiation, redifferentiation, or transdifferentiation processes. This chapter de-
scribes the source of the stem cells.
5.2.1 Resident stem cells
Resident stem cells can be divided into two groups (i) pluripotent cells and (ii) reactivated tissue progenitor
cells.
(i) Hydra has interstitial stem cells, located in the extracellular matrix which separates two single germ
layers - the endoderm and the ectoderm (Galliot, 1997). All three cell types are able to self-renew, thus
this animal is considered negligibly senescent (Martinez, 1998). In addition, interstitial stem cells can also
produce neurons, nematocytes, secretory cells and gametes.
Another animal containing residential pluripotent stem cells is planaria. The pluripotent proliferative pre-
existing cell population in adult planarians is called neoblasts. Neoblasts, are an essential cell source for
regenerative processes in planaria, since they give rise to regenerating blastema cells - the key for the re-
generative event. Irradiation of neoblasts and thus killing of these proliferative cells however, leads to death
of the organism (Lange, 1968; Curtis and Hickman, 1926). When single clonogenic neoblasts were trans-
planted into lethally irradiated host, the neoblasts were able to generate all adult cells, such as the head
containing neurons (ectoderm), muscle cells (mesoderm), and intestine (endoderm) (Wagner et al., 2011).
However, since the clonogenic neoblast implanted into irradiated host was from an asexual strain, it can not
be concluded whether single neoblasts can also regenerate gonads. The clonogenic neoblasts could restore
the regeneration of the lethal host, indicating that at least a subset of neoblasts are pluripotent stem cells.
It had been reported that neoblasts contain genes necessary for pluripotency in embryonic stem (ES) cells,
including regulators and targets of OCT4 (Onal et al., 2012).
(ii) The second group of resident stem cells are tissue progenitor cells which are usually quiescent but can
become reactivated after e.g. an injury. One example is the mononuclear satellite cells in mature muscle
tissue. The cells are quiescent. However, after an injury they become activated and re-enter the cell cycle.
Satellite cells form new myofibers in a process similar to muscle development in the embryo.
5.2.2 Reprogrammed somatic cells
The process of reprogramming somatic cells during regeneration can be categorized into two groups: (i)
dedifferentiation followed by redifferentiation, or (ii) dedifferentiation followed by transdifferentiation. The
transdifferentiation process can be either restricted or non-restricted. However, in literature the terms are
not used in a consistent manner.
Dedifferentiation is a process where a differentiated cell returns to a stage earlier in development.
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(i) Redifferentiation defines a process by which a once dedifferentiated cell returns to the original cell type.
This is a lineage restricted process.
Kragl et al. (2009) had shown that during axolotl limb regeneration muscle cells regenerate only muscle, and
not cartilage or epidermis. However, in their study it is unresolved whether the regenerated muscle cells
derived from dedifferentiation of muscle cells followed by redifferentiation, or whether the muscle formation
takes places due to satellite cells (see chapter 5.2.1 (ii)).
Recently it had been shown that mature osteoblasts from zebrafish dedifferentiate in regenerating bone fin
tissue (Knopf et al., 2011). After amputation, mature osteoblasts dedifferentiate, and due to fibroblast growth
factor (FGF) signaling cells, proliferate before they migrate further distal to form part of the blastema. During
regenerative outgrowth of the fin blastema cells derived from osteoblast redifferentiate only into osteoblasts
but no other cell type, which means that their cell fate is restricted and dedifferentiation is not associated
with obtaining a multipotent cell state (Knopf et al., 2011).
(ii) Transdifferentiation describes a process in which the somatic dedifferentiated cell converts into another
somatic cell type. This transdifferentiation process is either (a) restricted or (b) non-restricted.
(a) It was reported that amputated fin rays from zebrafish can regenerate de novo osteoblasts (Singh et al.,
2012). The researchers used a genetic ablation technology to destroy all skeletal osteoblasts in adult zebrafish
fin. The organism was able to restore the osteoblast population within two weeks after amputation. This
experiment showed that the new bone can form from a source other than dedifferentiated osteoblasts. There
is a multiple cell source, including nonosteoblasts with the potential to contribute to bone regeneration
(Singh et al., 2012). The scientists suggest that the predominant cell type for nonosteoblasts would be
intraray fibroblasts. Intraray fibroblasts express similar markers like osteblasts (e.g. MSXb, MSXc, SOX9a,
COL2a1) (Akimenko et al., 1995; Smith et al., 2006), which in mammals is known to induce osteoblast cell
fate (Karsenty, 2008).
Experiments in salamanders showed that new bone tissue can regenerate after removal of the skeletal elements
followed by amputation through this area (Thornton, 1938). Kragl et al. (2009) had shown that dermal cells
in axolotl limb are able to form cartilage and tendons during regeneration. The different cell types have a
close lineage relationship since all arise from lateral plate mesoderm (Kragl et al., 2009). However, from this
study it is unclear whether this process is transdifferentiation from dermal cells or whether there are resident
stem cells in the limb.
Another example of transdifferentiation is the process of lens regeneration in newt. Early after injury,
differentiated iris cells lose its differentiated phenotype and re-enter the cell cycle (Maki et al., 2009) (see
chapter 7.1.2). Afterwards cells transdifferentiate and form the lens tissue. The researchers showed that
stem cell pluripotency-inducing factors are expressed during lens regeneration. They hypothesize that the
factors regulate a tissue-specific reprogramming (Maki et al., 2009) (see chapter 5.3.1). This restricted
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transdifferentiation process is further supported by observations from transplantations of reaggregated dorsal
iris pigment epithelial cells (PEC) into blastema of forelimb in newt (Ito et al., 1999) (see chapter 7.1.2). Ito
et al. (1999) showed that the cells are only able to form lens tissue.
(b) A non-restricted transdifferentiation process takes place in anthomedusa. Here, isolated striated muscle
fragments can undergo a pluripotent transdifferentiation and form smooth muscle cells, glandular cells, and
even endoderm, nematocytes, digestive secretory gland, interstitial, and nerve cells (Schmid and Alder, 1984).
This transdifferentiation to a completely new cell types indicates, that the dedifferentiated cell must have a
potent character to be able to form each cell type.
The colonial tunicate Botrylloides leachi is able to regenerate functional adults from minute vasculature
fragments, by a process called Whole Body Regeneration. Rinkevich et al. (2010) found that the Whole Body
Regeneration takes place through activation, mobilization and expansion of ”dormant” internal vasculature
epithelium cells. These cells express PIWI, a bona fide stemness marker for self-renewal and maintenance
of germ line and somatic stem cells in multicellular organisms (Carmell et al., 2007; Kuramochi-Miyagawa
et al., 2004; O’Donnell and Boeke, 2007). Hence, the PIWI expressing cells change morphology, proliferate
and differentiate, and can regenerate a new intact organism (Rinkevich et al., 2010).
5.3 Pluripotency network
Pluripotency refers to a cell that has the potential to differentiate into any kind of fetal or adult cell made
from the three different germ layers, the ectoderm, mesoderm and endoderm.
It has been shown recently, that a differentiated mammalian cell can be reprogrammed artificially to become
an induce pluripotent stem (iPS) cell that can differentiate to various tissue types (Takahashi and Yamanaka,
2006). It was shown by in vitro studies that mouse embryonic and adult fibroblast cultures as well as many
other differentiated cell types can be induced to form pluripotent stem cells by four transcription factors
through overexpression: OCT4 (also called POU5f1) , SOX2, c-MYC and KLF4 (Takahashi and Yamanaka,
2006; Wernig et al., 2007; Aasen et al., 2008; Huangfu et al., 2008b; Kim et al., 2009b; Takahashi et al.,
2007; Loh et al., 2009). NANOG is another factor that seems to play an important role in pluripotency and
the reprogramming event (Wernig et al., 2007; Okita et al., 2007; Yu et al., 2007; Takahashi and Yamanaka,
2006). These transcription factors are expressed in ES cells (Mitsui et al., 2003; Niwa et al., 2000; Scholer
et al., 1990) and in the early embryo (Nichols et al., 1998) and are essential to maintain a pluripotent cell
state.
It would be interesting to know whether the in vitro reprogramming to iPS cells and the in vivo reprogramming
event during regeneration share any similarities. The pluripotency factor OCT4 is a reprogramming factor
to generate iPS cells. The involvement of Oct4 during regeneration processes in different organisms had been
studied to some extend and will be described in the following chapters.
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5.3.1 Expression of pluripotency associated factors in regenerating urodeles
Maki et al. (2009) investigated pluripotency-inducing factors during limb and lens regeneration in newt. They
collected tissue of six limbs on the day of amputation, and regenerating tissue from each of six animals at 7
(early blastema stage) and 15 days post amputation (dpa) (late blastema stage). They observed significant
up-regulation of Sox2, c-Myc and Klf4 with the emergence of blastema formation. c-Myc expression decreased
after day 7. The pluripotency-associated genes Oct4 and Nanog however, were not detected by quantitative
polymerase chain reaction (PCR). During lens regeneration, Sox2 and Klf4 showed up-regulation in very
early regenerating stages (2 dpa), a feature typical to prepare pre-existing tissue for reprogramming and cell
cycle re-entry (Maki et al., 2009). This correlates with establishing the lens vesicle. On the other hand c-Myc
mRNA peaked at day 8 post lentectomy, characteristic for establishing the vesicle. Since Sox2, c-Myc and
Klf4 mRNA were expressed in different stages during regeneration, and Oct4 and Nanog mRNA were absent,
this may explain why regenerating newt cells are not pluripotent (Maki et al., 2009).
Interestingly, Oct4 and Nanog mRNA are expressed in ovarian tissue indicating that newt contains both
genes (Maki et al., 2009).
Oct4 in axolotl was identified by Bachvarova et al. (2004). They localized Oct4 mRNA in the posterior
mesoderm of late gastrula stage embryos that gives rise to primordial germ cells, as well as in diplotene growing
oocytes. However, they did not perform regeneration studies to investigate OCT4 expression (Bachvarova
et al., 2004).
Jhamb et al. (2011) performed an in silico analysis of network based transcription factors in regenerating
axolotl limb to understand protein interactions present in blastema formation during limb regenerative pro-
cesses. The most interconnected transcription factors in this study were c-MYC, specificity factor1 (SP1),
the hepatocyte nuclear factor 4-alpha, the estrogen receptor1 and cellular tumor antigen p53. c-MYC was the
factor which interacted most. Further, they identified the epigenetic reprogramming factors KLF4, OCT4,
and LIN28 which interacted with c-MYC and SP1. However, they did not state whether the reprogramming
factors are upregulated during limb regeneration.
5.3.2 Expression of pluripotency associated factors in regenerating xenopus
Christen et al. (2010) studied limb and tail regeneration in xenopus at four different time points: (i) non-
regenerating tissue (0 dpa), (ii) blastema formation (1 dpa), (iii) blastema expansion (3 dpa) and (iv)
blastema redifferentiation (5 dpa) performing quantitative real time PCR (Christen:2010p198). They com-
pared the results to those obtained from cells of the animal cap, which were used as pluripotent control cells.
A further control was made by using regenerating incomplete limbs during metamorphosis, a time when
xenopus loses its regeneration capacity.
Christen et al. (2010) showed that in the tail, the mRNAs of the pluripotency associated factors Zic3, Tert-A,
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Dppa2/4 and Sall4 were expressed at a lower level in 1 dpa and 3 dpa compared to cells of the animal cap.
The two reprogramming factors Sox2 and c-Myc, and Fut-1, an early marker in the reprogramming process,
however, were expressed similarly or even at higher level in 1 dpa to 5 dpa samples. However, they did not
detect any of the xenopus Pou homologs Pou25, Pou60, Pou79, Pou91 in the tail at the time points tested.
In limb regeneration, Zic3mRNA was not expressed in the time points tested (Christen et al., 2010). Dppa2/4
did show expression but at a very low level. Sall4 mRNA expression peaked on 1 dpa, but the level was lower
than in pluripotent animal cap cells. Sox2 mRNA was highly upregulated in non-regenerating tissue (0 dpa)
compared to animal cap cells and the level decreased over time. c-Myc did not show a significant change in
expression levels during limb regeneration, and xenopus Pou homologs were not detected in the tested time
points (Christen et al., 2010).
Interestingly, in regenerating incomplete limbs from xenopus Christen et al. (2010) also detected Sox2, c-Myc
and Fut1 mRNA upregulation that peaked at 1 dpa and decreased to the level of non-regenerating limbs by
3 dpa. However, they did not further speculate on that observation. The investigators also observed a higher
mRNA level of c-Myc in the older limbs than in young limbs.
The shortcoming of this study is that the expression levels mentioned here were compared to cells of the
animal cap, a pluripotent cells source. However, since these are cells in a developing embryo, it cannot be
compared to expression levels in regenerating cells directly. The results would have had more significance had
the expression levels of the regenerate been compared to the levels obtained using mature non-amputated
tissue.
5.3.3 Expression of pluripotency associated factors in regenerating zebrafish
Regeneration studies on zebrafish fin investigating the role of pluripotency related genes Pou2, Klf4, Sox2,
c-Myc, Tert, Zic3, Hsp90a and Sall4 was also performed by quantitative real time PCR (Christen et al.,
2010). The researchers compared the expression of these factors in both regenerating (four different time
points) and non-regenerating limbs to blastula stage embryos, a pluripotent cell source and thus expressing
all eight pluripotency related factors.
Pou2, Klf4 and Sall4 mRNA expression in early regenerating fin was significantly lower compared to blastula
stage embryos (Christen et al., 2010). All three factors have also been present in non-regenerating fin, but at
much lower level than in the blastula. c-Myc, Tert, Zic3 and Hsp90a mRNA showed similar expression levels
in non-regenerating fin and blastula stage embryos (Christen et al., 2010). Sox2 mRNA on the other hand
was upregulated in non-regenerating fin in contrast to blastula embryo (Christen et al., 2010). However, none
of the tested markers showed an upregulation in the process of fin regeneration.
Again, it is not clear why the investigators chose to compare the expression levels of regenerating fin to
blastula stage embryos and not to levels in non-amputated fin tissue.
It was reported that regeneration of retina tissue induces expression of some pluripotency factors (Ramachan-
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dran et al., 2010). The proneural transcription factor Ascl1a induces the microRNA-binding protein LIN-28
expression in Mu¨ller glia cells after injury. Mu¨ller glia cells are cells giving rise to neurons in the retina
upon injury. LIN-28 suppresses Let-7 microRNA and hence blocks expression of the regeneration-associated
genes Ascl1a, Lin-28 and Pou2 (Ramachandran et al., 2010). POU2 protein shows a low expression in
uninjured retina. It is assumed that Let-7 represses this expression to prevent premature Mu¨ller glia cells
dedifferentiation (Ramachandran et al., 2010).
5.4 Aim of this thesis
It is well known that the mammalian transcription factor Oct4 (also called Pou5f1), a class V POU gene (see
also chapter 6.1.2), is responsible in maintaining pluripotency in developing embryos. Further, it is a key
factor in reprogramming differentiated cells. An Oct4 ortholog was also identified in Ambystoma mexicanum
- the axolotl, a salamander with remarkable abilities of regeneration. However, it is unclear whether axolotl
OCT4 has a similar effect like the mammalian OCT4. In general, it is unknown whether reprogramming of
cells during regenerative processes, and reprogramming of somatic cells to generate induced pluripotent stem
(iPS) cells, share any similarities.
We are interested in the involvement of pluripotency genes Oct4 and the newly identified Pou2, as well as
the gene for the transcription factor Sox2 in regenerating axolotl spinal cord. Is the pluripotent character of
POU factors limited to mammals or is it an ancient characteristic of lower vertebrates? However, this model
organism would be a very complex in vivo system with which to study pluripotency. Thus, we decided first
for the simpler system of using an in vitro assay to investigate the pluripotent ability of the POU factors.
Therefore this work is separated into two chapters:
(1) Reprogramming to pluripotency is an ancient trait of vertebrate OCT4 and POU2 proteins
So far, only studies about the maintaining of ES cell pluripotency using class V POU proteins from different
vertebrate species have been performed (Morrison and Brickman, 2006). However, it is not clear whether
class V POU proteins from different species are able to generate iPS cells. To our knowledge this is the first
study investigating pluripotent character of different PouV homologs.
We first identified a new gene, Pou2, a member of the class V POU family, in axolotl and examined whether
the Pou2 ortholog is different from the already identified putative Oct4 sequence. Phylogenetic analysis
showed a clear distinction of both genes in the axolotl. Afterwards we determined the mRNA pattern of
Pou2 during embryogenesis and compared it to Oct4 mRNA and protein. Both genes are expressed in the
pluripotent animal cap region of the embryo. Apart from this similarity, both genes have a different expression
pattern. Next, we wanted to know whether the axolotl POU2 as well as the axolotl OCT4 have a potent
character like POU orthologs in other species. Therefore, we performed reprogramming experiments using
mouse or human fibroblasts and transduced them with axolotl Pou2 or Oct4, in combination with human or
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axolotl Sox2, c-Myc and/or Klf4. Furthermore, we compared the reprogramming ability with POU factors
from mouse, human, zebrafish, medaka and xenopus. The iPS cells generated were further characterized in
terms of their endogenous pluripotency gene expression profile.
(2) Regenerating spinal cord cells are pluripotent
We investigated the role of Pou2, Oct4 as well as Sox2 gene expression in regenerating spinal cord tissue to
determine whether OCT4 and POU2 have similar pluripotent character as it was shown in our in vitro studies.
We performed in situ hybridizations and antibody staining to localize the factors in the regenerating spinal
cord. Sox2 and Oct4 were expressed during spinal cord regeneration and thus we wanted to know whether
these cells would also have a pluripotent character in vivo, meaning that cells would not be restricted in
their linage but rather able to form other tissue types. To investigate this, we performed transplantations of
enhanced green fluorescence protein (EGFP) labeled spinal cord into somite stage embryos and showed the
formation of muscle cells.
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6 Chapter I: Reprogramming to pluripotency is an ancient trait
mediated by vertebrate OCT4 and POU2 proteins
6.1 Introduction
6.1.1 Composition and interactions of OCT4 - a class V POU transcription factor
The name POU is an abbreviation from three transcription factors. ”P” stands for the Pituitary-specific
Pit-1, ”O” for the octamer transcription factors Oct-1 and Oct-2 with an octamer sequence of ATGCAAAT
and ”U” for the neural transcription factor Unc-86. The POU family consists of 14 different members, which
all have the conserved POU domain, and a variable N- and C-terminus in common.
The POU domain is composed of two subunits separated by a non-conserved flexible linker region of 15 to
55 amino acids. The N-terminal subunit is named the POU specific domain and the C-terminal subunit is
the homeobox domain.
In order to bind to the target genes OCT4 forms a heterodimer with SOX2. SOX2, the short form of SRY (sex
determining region Y)-box 2, is a SOX family transcription factor. This family features a highly conserved
DNA binding domain called High-mobility group (HMG) box domains which contains approximately 80
amino acids. To bind to target genes, the POU domain of OCT4 has to first interact with the HMG domain
of the transcription factor SOX2 to form a heterodimer on the promoter region of the target DNA (Ambrosetti
et al., 2000). The target DNA has a specific character of the OCT4/SOX2 binding sites (Badis et al., 2009;
Ambrosetti et al., 2000). The binding leads to a stronger interaction of DNA and protein domains, and
activates intrinsic activation domains of the proteins. Interactions between proteins and protein-DNA can
result in conformational changes causing activation of gene expression (Ambrosetti et al., 2000).
OCT4 and SOX2 dimerization activate many different promoters of pluripotency-associated genes (Remenyi
et al., 2003), and thus contribute to the pluripotent state of a cell (Boyer et al., 2005).
Next to OCT4, NANOG is another homeodomain transcription factor which essentially regulates ES cell
identity and early development by maintaining pluripotency of cells (Nichols et al., 1998; Mitsui et al.,
2003). Genetic mouse studies showed that both intrinsic factors have distinct roles but they may function
in related pathways. Hence the regulators maintain the developmental potential of ES cells (Chambers,
2004). It was shown that disruption of NANOG and OCT4 leads to inadequate differentiation of ES cells
and ICM to extra-embryonic endoderm and trophectoderm respectively (Mitsui et al., 2003; Nichols et al.,
1998; Chambers et al., 2003). On the other hand, overexpression of OCT4 in ES cells results in a similar
phenotype to the loss of NANOG function (Chambers et al., 2003; Mitsui et al., 2003; Nichols et al., 1998;
Niwa et al., 2000).
Boyer et al. (2005) performed chromatin immunoprecipitation combined with DNA microarrays using human
H9 ES cells and determined target sites which are occupied by OCT4. They detected protein-DNA interac-
tion similar to analysis in mouse ES cells, including Oct4, Sox2, Nanog, Lefty2/ebaf, Cdx2, Hand1, Dppa4,
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Gja1/Connexin43, Foxo1A, Cripto/Tdgf1, and Zic3 (Abeyta et al., 2004; Brandenberger et al., 2004; Niwa,
2001; Sato et al., 2003; Kuroda et al., 2005; Wei et al., 2005; Okumura-Nakanishi et al., 2005). Results from
Boyer et al. (2005) indicate that OCT4, SOX2, and NANOG co-occupy the promoter regions of a large num-
ber of genes. In addition, many of these target genes encode homeodomain transcription factors necessary
in development, and further, these regulators contribute to ES cells identity.
6.1.2 Evolution of class V POU transcription factors
About 350 million years ago the first amphibial ancestors of frogs and salamanders evolved. Sauropsids
developed from basal amniotes approximately 320 million years ago. Their progeny are turtles, snakes,
lizards, crocodilians, and birds. About 90 million years ago synapsida evolved. The first monotreme mammals
developed and about 50 million years ago marsupials and placentals evolved. How the transcription factors
POU2 and OCT4 have evolved in these organisms has been discussed controversially. POU2 and OCT4 (also
called POU5f1), belong to the class V POU family. The different hypotheses for class V POU evolution are
discussed here.
(1) Niwa et al. (2008) reported first that Oct4 had only been identified in marsupials and eutherian mammals.
Zebrafish Pou2 and xenopus Pou91 were previously thought to be Oct4 orthologs (Burgess et al., 2002; Snir
et al., 2006). However, synteny analysis identified different genomic positions suggesting these genes are
paralogs (Niwa et al., 2008). These scientists claim that a single proto-orthologous class V POU gene existed
in ancestral jawed vertebrates, which is Pou2 related and gave rise to Oct4 by a gene duplication event in
early mammalian evolution. Co-existence of Oct4 and Pou2 in monotremes and marsupials, and Pou2 being
present in non-mammalian vertebrates from which Oct4 is absent support the gene duplication hypothesis
in early mammalian development (Niwa et al., 2008). It was considered that OCT4 is a mammal specific
transcription factor (Burgess et al., 2002; Niwa et al., 2008).
The initially identified Oct4 gene in axolotl, a salamander (and thus a lower non-mammalian vertebrate)
showed an protein sequence similarity of 88% to mammalian OCT4. It was the most closely related ortholog
to mammals identified at that time (Bachvarova et al., 2004).
(2) Frankenberg et al. (2010) have also investigated the evolution of class V POU domain transcription factors
and refute the previous hypothesis. They affirm that there was a gene duplication event in the ancestral class
V POU during early evolution of tetrapods when Oct4 arose from Pou2. This means that Oct4 is not mammal
specific, as previously described. Using BLAST search they did not detected a Pou2 ortholog in lamprey,
lancelet, or tunicate genomes. But they identified at least one Pou2 ortholog in higher taxa, indicating that
class V POU domain transcription factors generated during gnathostome evolution (Frankenberg et al., 2010).
Besides Oct4 and Pou2 orthologs present in platypus and opposum (Niwa et al., 2008), they also found both
orthologs in tammar (Frankenberg et al., 2010). Investigation of the axolotl OCT4 (Bachvarova et al., 2004)
and the assembled sequence of lizard OCT4 showed a significant protein similarity to other OCT4 factors.
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This conclusion is supported by two more observations. First, there is a conserved transcription starting
sequence, MAGH, at the N-terminus which is not present in all other analyzed putative Pou2 orthologs.
On the other hand, there is an absence of a single arginine residue in all Oct4 orthologs within the POU
specific domain (see chapter 6.1.1). These characteristics are highly unlikely to have occurred independently
in different lineages. An additional verication of the relationship among class V POU genes was performed
by synteny analysis. Since, the lizard genome was not completely known, the synteny is at least conserved
with respect to OCT4 (Frankenberg et al., 2010). Hence, the scientists concluded that lizard Oct4 is an
orthologue of mammalian Oct4. Further, they claimed that there was a gene duplication in early tetrapod
evolution where Oct4 arose from Pou2 (Frankenberg et al., 2010). Actinopterygii like zebrafish and medaka,
aves (e.g. chicken), and amphibia from the anura order (e.g. frog) have retained Pou2. On the other hand
urodeles like axolotl and reptilian (e.g. lizard), and eutherian like mouse and human mammals kept the Oct4
gene (Frankenberg et al., 2010; Bachvarova et al., 2004).
6.1.3 Expression of class V POUs during embryonic development
The mammalian Oct4 encodes for a key regulator to maintain pluripotent character in ES cells (Boyer et al.,
2005; Rodda et al., 2005; Scholer, 1991), the inner cell mass, and the epiblast. After gastrulation OCT4 is
downregulated. The cells maintaining OCT4 expression are the posterior epiblast and the primitive streak
(Morrison and Brickman, 2006) as well as the primordial germ cells (reviewed in Pesce and Scholer (2001))
to facilitate germ cell lineage (Frankenberg et al., 2010; Boyer et al., 2005; Rodda et al., 2005; Scholer, 1991;
Pesce and Scholer, 2001; Kehler et al., 2004).
In mouse, OCT4 is also expressed after gastrulation until the 16-somite stage embryo (Downs, 2008). At
headfold stage, OCT4 is present in surface ectoderm and neural ectoderm of caudal node, which is the anterior
end of the primitive streak formed in early gastrulation (Downs, 2008) (see also chapter 7.1.3).
In zebrafish Pou2 is also involved in early embryo development. mRNA was observed from the one-cell
stage to the gastrula stage embryos (Takeda et al., 1994). Pou2 mRNA was found in blastomeres until the
midblastula stage. During gastrulation the expression was restricted to the epiblast (Takeda et al., 1994).
Xenopus laevis contains three POU factors, OCT25, OCT60 and OCT91 (Cao et al., 2006, 2010). In this
thesis they are referred as POU25, POU60 and POU91, respectively. POU25, POU60 and POU91 are
expressed during oogenesis and early embryogenesis (Hinkley et al., 1992). Pou25 mRNA was localized at
low levels in oocytes and cleavage-stage embryos and reached its maximum during gastrulation (Hinkley
et al., 1992). Pou60 mRNA was located in the animal hemisphere of mature oocyte (Hinkley et al., 1992)
and accumulated after fertilization (Whitfield et al., 1995). The highest mRNA level was observed in the
animal cap of mid-blastula embryo (Whitfield et al., 1995). Pou91 mRNA levels increased after midblastula
transition and peaked during late gastrulation (Whitfield et al., 1995). The expression of all three genes
decreased during late gastrulation and early neurulation.
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All these factors have in common that they are expressed during early embryonic development and maintain
the pluripotent character of the embryonic cells.
6.1.4 Self-renewal and pluripotent ability of class V POU transcription factors
Morrison et al. investigated the conserved roles for OCT4 homologues concerning the maintainance of
multipotency during early vertebrate development (Morrison and Brickman, 2006). Since Oct4 is essential
for ES cell self-renewal (Niwa et al., 2000) they tested POU V proteins from xenopus, axolotl and zebrafish
for the ability to substitute Oct4 in mouse ES cells. For these in vitro rescue studies they used Oct4-/-
knockout mouse murine ES, and electroporated the cells with plasmid constructs encoding for one of the
POU factors. They measured the extent of Oct4 rescue conveyed by the production of ES cell-like alkaline
phosphatase positive colonies, as well as the generation of clonal cell lines in long-term self-renewal, and by
the expression of ES cell specific proteins. The investigators showed that Pou91 has the ability to rescue
the wild type phenotype in Oct4-/- knockout cells (Morrison and Brickman, 2006). Pou60 and Pou25 from
Xenopus laevis as well as Oct4 from axolotl has some capacity to rescue ES cell self-renewal in the absence
of endogenous Oct4 (Morrison and Brickman, 2006). On the other hand, Morrison and Brickman (2006)
reported that zebrafish Pou2 is not able to substitute for Oct4 in ES cells nor to rescue the Xenopus PouV
depletion phenotype.
Studies using the chicken PouV ortholog demonstrated the maintenance of pluripotency and self-renewal
ability of chicken ES cells (Lavial et al., 2007a).
These different behavior of vertebrate Oct4/Pou2-like homologs in the rescue ability suggests a variability in
self-renewal activity between the Oct4 and Pou2 genes (Niwa et al., 2008; Morrison and Brickman, 2006).
6.1.5 Reprogramming of somatic cells to generate induced pluripotent stem cells
Induced pluripotent stem (iPS) cells are a cell type similar to pluripotent stem cell but generated artificially
from non-pluripotent somatic cell. The induction is triggered by the expression of maximally four proteins:
OCT4, SOX2, KLF4 and c-MYC, first shown by Takahashi and Yamanaka (2006).
The researchers tested 24 gene candidates encoding proteins which play a role in maintaining ES cell state
and evaluated them in a G418 resistance in vitro assay. They inserted β-galactosidase and neomycin re-
sistance genes (βgeo) into the mouse Fbx15 gene (Tokuzawa et al., 2003). ES cells were resistant to high
concentrations of G418 in culture, whereas somatic cells were sensitive to a normal concentration. Mouse
embryonic fibroblasts (MEF) from homozygous (βgeo) knockin Fbx15 mouse were transduced with retrovirus
(Morita et al., 2000) encoding for the 24 candidate factors.
They identified OCT4, SOX2, KLF4 and c-MYC as the factors inducing pluripotency. In contrast, NANOG
is not necessary for induction and maintenance of iPS cells.
The iPS cells have similar characteristics to stem cells e.g. the expression of stem cell marker proteins such
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as NANOG, OCT4, SSEA4; the embryoid body and teratoma formation (Takahashi and Yamanaka, 2006)
and the chromatin methylation pattern of the promoter.
Generating iPS cells from somatic tissue might prove to be of huge importance for treating diseases like spinal
cord injury, and because cells generated from their own somatic tissue cells avoid both the ethical difficulties
regarding the application of human embryos and the tissue rejection after an transplantation in patients.
6.1.6 The goal of this project
In early tetrapod evolution the ancestral class V Pou gene duplicated and gave rise to Oct4 and Pou2
(Frankenberg et al., 2010). Both transcription factors are responsible in maintaining pluripotency in early
developing embryos. Further, some of the factors have the ability to confer self-renewal to ES cells.
Axolotl has Oct4 and Pou2. However, it is not clear whether the factors have a similar potent conferring
ability like the mammalian OCT4. Is the pluripotent character of cells expressing POU factors limited to
mammals or is it an ancient character of lower vertebrates? It is unknown whether PouV proteins from
different species are able to generate iPS cells. We used an in vitro assay to investigate the pluripotent ability
of different POU factors.
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6.2 Results
This part of the thesis was a joined project with the group of Prof. Dr. Hans Scho¨ler from MPI for Molecular
Biomedicine in Mu¨nster. They performed all reprogramming studies and the analysis of reprogrammed cell
lines.
In the following experiments we applied axolotl and human transcription factors. For clarity we use lower
case characters when axolotl factors AxOct4 (o), AxPou2 (p) and AxSox2 (s) were applied. On the other
hand capital letters symbolize the human factors Oct4 (O), Sox2 (S), Klf4 (K) and c-Myc (M).
6.2.1 Identification of the Pou2 gene in axolotl
Prior to this work, a Pou2 ortholog in axolotl had not been identified. We were interested whether axolotl
has also Pou2 as well as Oct4, first isolated and identified by Bachvarova et al. (2004). If so, we wanted to
know whether the Pou2 ortholog can be distinguished from the existing putative Oct4 sequence. To examine
this we carried out a BLAST search on contiguously assembled expressed sequence tags (ESTs) which we
obtained from Sanger, and 454 sequences using the AxOct4 sequence. We identified a single partial sequence
which was similar but different to the known Oct4 sequence. BLAST search with the identified new sequence
determined the vertebrate Pou2 family members as the closest orthologs. We performed a screening of our
axolotl long-insert cDNA library to define the entire Pou2 coding sequence which is shown in Figure 1. The
Pou2 coding sequence has a length of 1359 base pairs which corresponds to a POU2 protein sequence of 453
amino acids. BLAST analysis showed that the putative protein sequence has a variable N- and C-terminus,
and a POU domain composed of two subunits, the POU specific domain and the homeobox domain.
Figure 1: Coding region of axolotl Pou2 sequence
Axolotl Pou2 was isolated from our long-insert cDNA library using primers designed from the identified
contig sequence. The insert was sequenced, and the coding sequence (green) and deduced protein sequences
(black) are shown here.
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6.2.2 Phylogenetic analysis of class V POU proteins shows that axolotl has Pou2 and Oct4
ortholog
OCT4/POU2 orthologue sequences
(POU60)
(POU60)
(POU25)
(POU25)
(POU91)
(POU91)
Figure 2: Phylogenetic tree of POU factors from various species
Shows the phylogenetic tree of OCT4 and POU2 homologs from a variety of species. The assembly of the
POU sequences suggests that axolotl has the Pou2 as well as the Oct4 homolog. Branches are labeled with
their relative length and the posterior probabilities are marked at the corresponding nodes. As an outgroup
BRN3C from zebrafish was used. OCT1 and OCT6 sequences, and the dotted branches indicate the split
of the subtree of the OCT4/POU2 sequences. The length of the dotted branches is not scaled. Xenopus
OCT25, OCT60 and OCT91 are referred here as POU25, POU60 and POU91, respectively.
We identified Pou2 in the axolotl. We want to know whether the axolotl Pou2 is a true Pou2 ortholog or an
Oct4 ortholog.
We therefore identified the gene orthology of the putative axolotl POU2 and the OCT4 by performing
a multiple sequence alignment from various species. The conclusion using either the entire POU protein
sequences or of only the POU DNA-binding domains for analysis, were the same. The phylogenetic tree
illustrated in Figure 2 is based on the multiple sequence alignment of the DNA-binding domains in the POU
factors.
We observe a splitting of class V POU factors into two major branches, one for OCT4 sequences the other one
for POU2. The POU2 branch is divided into three different sub-categories. We monitored a cluster formation
of the newly identified axolotl POU2 sequence together with POU2 sequences from chicken, platypus, opossum
and tammar. In addition, a distinct sub-branch is formed by assembling the POU2 sequences from stickleback,
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medaka, cod, zebrafish and carp. Xenopus POU class V ancestor gene underwent a gene duplication in
evolution. Thus, we observed a separate branch for the different xenopus POU orthologs POU25, POU60
and POU91.
On the other hand, the OCT4 sequence from axolotl clusters with sequences from lizard, platypus, tammar
and different eutherian mammals like rabbit, mouse, chimpanzee and bovine.
Our results indicate that axolotl Pou2 and Oct4 are clearly distinguishable genes. This means that like
marsupials and monotremes the axolotl has both Pou2 as well as Oct4 ortholog and both belong to the class
V POU domain proteins. This shows that Pou2/Oct4 orthologs can be traced back to a gene duplication at
the beginning of early tetrapod lineage.
6.2.3 Synteny analyses of axolotl Oct4 and Pou2 support orthology to Oct4 and Pou2, respec-
tively
To confirm the genetic relationship of axolotl Oct4 and Pou2, our collaborators Kevin Kump and Randal
Voss analyzed the conserved synteny on these genes. Synteny analysis is used to study the genetic and thus
the evolutionary relationship of different species by examining the physical co-localization of genetic loci on
the same chromosome within an organism. This method is based on genetic linkage, which describes the
location of genes on a chromosome.
Zebrafish 65 kb
Chicken 22 kb
Mouse 25 kb
Human 12 kb
AxNpdc1
AxPou2
AxTcf19
AxOct4
AxCchrc1
Tcf19
Lg16
Lg17
Pou2
Npdc1
Oct4
Cchrc1
Figure 3: Synteny analysis of axolotl Oct4 and Pou2
Assignment of AxPou2 and AxOct4 to Ambystoma linkage group (Lg) 16 and 17, respectively. AxPou2
sequence mapped to the position of AxNpdc1 (20 cM) and AxOct4 (76 cM) mapped to the position of
AxTcf19 and AxCchrc1. The linkage relationships of Pou2-Npdc1 and Oct4-Tcf19-Cchrc1 show conserved
syntenies in chicken-zebrafish and mouse-human, respectively. Thanks to Kevin Kump and Randal Voss who
performed this experiment.
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They positioned axolotl Pou2 (AxPou2) and axolotl Oct4 (AxOct4) within the Ambystoma genetic linkage
map based on AxTg mapping panel (Voss et al., 2011). The analysis is shown in Figure 3.
We could show that AxPou2 maps to the position of AxNpdc1 (LG16, 20 cM), AxOct4 on the other hand
to AxCchcr1 and AxTcf19 (LG17, 76 cM). A tight physical linkage of Pou2-Npdc1 was noticed in chicken
and zebrafish. For Oct4-Cchcr1-Tcf19 we noted a tight physical linkage to human and mouse. This result is
another support of the orthology of axolotl Pou2 and Oct4.
6.2.4 Localization of axolotl Oct4 and Pou2 during embryogenesis
Axolotl Oct4 was already shown to be highly abundant in gastrula stage embryos by Northern blot analysis
(Bachvarova et al., 2004) and they localized Oct4 mRNA in cells of the ectoderm and presumptive mesoderm.
We wanted to compare mRNA and protein of Oct4 and Pou2, and determine whether the factors are expressed
in pluripotent cells. Therefore, we performed in situ hybridization on blastula and gastrula stage embryos
(Figure 4 A).
We observed a weak Oct4 mRNA expression level in the animal half of blastula stage embryo. The Oct4
mRNA becomes more abundant in the ectodermal surface of gastrula stage embryo. Oct4 mRNA is expressed
in the animal cap region, an area with pluripotent cells and thus equivalent to the mouse epiblast. Oct4
was also localized in the blastopore lip of gastrula stage embryos, a region similar to the primitive streak in
mouse.
To determine OCT4 protein in gastrula stage embryos we performed OCT4 antibody staining and observed
a similar expression pattern of OCT4 protein when compared to Oct4 mRNA pattern (Figure 4 B). OCT4
was expressed in the animal cap region as well as the blastopore lip.
In addition to the localization of Oct4 we also performed Pou2 in situ hybridization on embryos. We detected
Pou2 similarly to Oct4 in the ectoderm of blastula and gastrula stage embryos (Figure 5 A and B respectively).
Pou2 is highly abundant in cells of the animal cap region and the blastopore lip in gastrula stage embryos.
In contrast to Oct4, Pou2 was still expressed in the ectoderm and mesoderm of late neurula I stage embryos,
a phase when the neural folds are close to each other but not yet fused (Figure 5 C). In late neurula IV stage
embryos, where neural folds are fused in the spinal region, Pou2 was localized in the hindbrain (Figure 5
D). This is similar to Pou2 expression in zebrafish, which is responsible for the formation of mid-hindbrain
boundary (Belting et al., 2001; Burgess et al., 2002).
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Figure 4: Oct4 mRNA pattern and OCT4 protein expression pattern in axolotl embryos
(A) Axolotl Oct4 mRNA in situ hybridization in blastula and gastrula stage axolotl embryos. For negative
controls the sense Oct4 probe was used, which did not show any background signal. In the right panel the
specific signal from the antisense probe is shown. The black arrowheads in gastrula stage embryos mark
the axolotl animal cap which is equivalent to the mouse epiblast. White arrowheads indicate the axolotl
blastopore lip, a region equivalent to the primitive streak in mouse. Scale bars 500 µm. (B) OCT4 in
gastrula stage embryo is expressed in ectoderm of the animal cap (red arrowhead) and the axolotl blastopore
lip (white arrowhead). Scale bar 500 µm.
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A B
C D
Stage 9 - Blastula Stage 11 - Gastrula
Stage 17 - Late neurula I Stage 20 - Late neurula IV
Figure 5: mRNA pattern of Pou2 in axolotl embryogenesis
(A) Pou2 is weakly expressed in blastula-stage embryos. (B) Pou2 transcript is abundant in the ectoderm of
the animal cap (black arrowhead) and the blastopore lip (white arrowhead) of an early gastrula-stage embryo
(C) as well as in the ectoderm and mesoderm of late neurula I stage embryos. (D) In late neurula IV stage
embryos Pou2 expression is located in the hindbrain. Scale bars 500 µm
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6.2.5 Axolotl Oct4 and Pou2 mRNA is expressed in gonia
Germ cell development takes place in the embryo by two different mechanisms depending on the organism.
In one mechanism cells are destined to become germ cells e.g. in drosophila. The second mechanism might
occur in OCT4 expressing organisms, e. g. mammals. Here, primordial germ cells are not specified at the
beginning of the embryonic development. The primordial germ cells are founder cells of the gametes, and
differentiate from pluripotent epiblast cells during gastrulation by mesodermal induction signals.
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Figure 6: Localization of Oct4, Pou2 and c-Kit transcripts in gonia of 3 cm axolotl larvae
(A), (B) and (C) show no background signal in the sense controls of Oct4, Pou2 and c-Kit respectively.
(D) Oct4 (E) Pou2 and (F) c-Kit shows a specific signal with the antisense probe in primordial germ cells
during axolotl development. Scale bars 100 µm. Black arrowheads mark primordial germ cells.
We were interested whether also axolotl primordial germ cells express Oct4 and whether Pou2 is also located
in this cell type. Hence, we performed in situ hybridization on 3 cm long axolotl larvae to investigate Oct4,
Pou2 and c-kit expression behavior in primordial germ cells (Figure 6). In contrast to previous experiments
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(Bachvarova et al., 2004) we identified Oct4 mRNA in primordial germ cells (Figure 6 D). We could also
detect weak Pou2 in primordial germ cells (Figure 6 E). Our positive control, the transcription factor and
oncogene c-Kit was also expressed in primordial germ cells (Figure 6 F) as was shown previously (Bachvarova
et al., 2004). Oct4, Pou2 and c-Kit show an overlapping mRNA pattern in developing gonia which is above
background level (Figure 6 A, B, C respectively).
6.2.6 Expression of axolotl Sox2 in embryogenesis
It is well known that activation of a pluripotency target gene promoter is regulated by the interaction of the
OCT4 POU domain with the SOX2 HMG domain (Ambrosetti et al., 2000). Since early embryonic expression
of axolotl SOX2 had not been previously described, we were interested whether Sox2 and the pluripotency
gene Oct4 are consistent in their mRNA expression pattern in embryos. Therefore we extracted RNA from
different embryonic stages and synthesized cDNA using reverse transcriptase (+ RT). We determined Sox2
expression above background signal (- RT) during early embryogenesis from cleavage stages (stage 8) to
neurula stage (stage 16) (Figure 7 A).
In situ hybridization of gastrula stage embryo showed Sox2 expression in the ectoderm to be especially highly
abundant in the pluripotent animal cap and weaker in the blastopore lip (Figure 7 B).
This shows that Sox2 localization in the embryo is consistent with the expression pattern of Oct4 and Pou2.
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Figure 7: Localization of Sox2 mRNA in axolotl embryos
(A) cDNA was synthesized from isolated RNA of embryonic stage 8 (cleavage), 9 (blastula), 11 (gastrula),
14 (early neurula) and 16 (late neurula) and used as template for PCR (+ RT). As negative control RNA was
not treated with reverse transcriptase (- RT). Electrophorezed amplified Sox2 product shows a significant
bands at 400 bp in all stages. (B) In situ hybridization on gastrula stage embryo shows no signal in the sense
control but Sox2 is strongly present in the ectoderm of the animal cap (black arrowhead) and less abundant
in the blastopore lip (white arrowhead). Scale bars 500 µm.
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6.2.7 Cell reprogramming to a pluripotent state is an ancient property of Pou2 homologs
We could show that Oct4 and Pou2, as well as Sox2 are expressed in the animal cap of gastrula stage embryos.
These cells are considered to have a highly pluripotent character (Ariizumi et al., 2009; Sive et al., 2007).
We were interested in the functional relationship of the POU orthologs and wanted to know whether factors
from different species have the ability to reprogram mammalian cells and make iPS cells. We used the POU
orthologs from mouse Oct4, human Oct4, axolotl Oct4 and Pou2, xenopus Pou91, zebrafish Pou2 and medaka
Pou2.
For this approach we collaborated with the group from Prof. Dr. H. Scho¨ler who performed the reprogram-
ming experiments.
The experimental strategy is illustrated in Figure 8 A. For the reprogramming experiment we used mouse
embryonic fibroblasts (MEF) which contained a green fluorescent protein (GFP) transgene driven by the
mouse Oct4 promoter (Yeom et al., 1996). MEF were transduced with retroviruses carrying mouse Sox2,
mouse Klf4, and mouse c-Myc, plus one of each different POU homologs: mouse Oct4, human Oct4, axolotl
Oct4, axolotl Pou2, xenopus Pou91, zebrafish Pou2 or medaka Pou2. After 14 days we determined the
reprogramming efficiency by measuring reactivation of GFP expression and calculated the percentage of
GFP expressing cells (Figure 8 B).
We showed that xenopus Pou91, as the only non-mammalian example, is nearly as efficient as mouse and
human Oct4 cDNAs in inducing GFP expressing cells. Also axolotl Pou2, axolotl Oct4 and medaka Pou2
showed reprogramming character, however at a much lower efficiency. In contrast, zebrafish Pou2 is not
able to establish iPS cells. This observation is fortified by Morrison and Brickman which demonstrated
that zebrafish Pou2 does not have the capacity to maintain pluripotency in mouse ES cells (Morrison and
Brickman, 2006).
We wanted to make sure that there is no cross-contamination between the different POU factors. To determine
this we selected two to three different iPS colonies for each of the tested homologs and genotyping the colonies
(Figure 8 C). All generated iPS cells using a certain POU factor showed a clean amplified product using their
respective primer, indicating that there was no cross-contamination between the different POU factors.
Furthermore, we investigated the reactivation and maintenance of GFP expression driven by the mouse
Oct4 promoter as well as alkaline phosphatase expression in the generated colonies. Therefore we performed
histochemical staining on the colonies and could show that all iPS cells generated with one of the different
POU factors are positive for GFP (Figure 8 D) and express alkaline phosphatase (Figure 8 E), a marker for
pluripotent cells.
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Figure 8: Generation and characterization of mouse induced pluripotent stem cells achieved
by applying various POU factors
(A)Mouse embryonic fibroblasts (MEF) contain a GFP transgene driven by mouse Oct4 promoter. On day 0
cells were transduced with pMX retroviruses coding for mouse Sox2, Klf4 and c-Myc in addition to one of the
Pou homologs. After 14 days the number of GFP expressing cells was measured by fluorescence-activated cell
sorting (FACS). (B) The result is illustrated as a percentage of the total number of cells and thus indicating
the reprogramming efficiency. Standard deviations were calculated from two independent experiments that
were run simultaneously. (C) To ensure that there is no crosscontamination between the different POU factors
we genotyped two to three of the derived mouse iPS cell colonies (indicated on the bottom, colony labeled
with 1, 2 or 3) which were generated by using different POU factors. Primers (indicated on the left) amplify
only one specific POU homolog. For each pair of primers, the clones containing the only POU homolog that
can be specifically amplified are considered to be positive controls; the rest of the clones are considered to be
negative controls. Amplified products for each primer pair were loaded into two different gels. (D) For each
Pou factor, one iPS clonal cell line is depicted for GFP and (E) alkaline phosphatase expression, a marker
for pluripotency. Generated iPS cells are marked as M, Mouse OCT4; H, Human OCT4; A, Axolotl OCT4;
AP, Axolotl POU2, K, Medaka POU2; X, Xenopus POU91. The number labels each different clonal cell line
established from each homolog. Experiments were performed by the collaborating group of H. Scho¨ler.
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We expect that the generated iPS cells express pluripotency markers. As further support for our hypothesis
we performed quantitative RT-PCR to determine the expression of the mouse pluripotency markers Oct4,
Nanog, Fgf4, Rex1 and Utf1 (Figure 9 A). All generated iPS cells show similar expression levels to two
different mouse ES cell lines used as a positive control. In contrast, as expected the initial fibroblast cell
population showed a significantly lower expression of the tested pluripotency markers.
An additional possibility to test the pluripotent character of the iPS cell is the establishing of teratomas in
vivo. Therefore, we performed a teratoma assay where one subcutaneously inject generated iPS cells into
nude athymic mice. All generated iPS cell clones differentiated into all three germ layers demonstrating its
in vivo pluripotent capacity (Figure 9 B).
In summary, our results indicate that mouse Oct4, human Oct4, axolotl Oct4, axolotl Pou2, medaka Pou2 and
xenopus Pou91 but excluding zebrafish Pou2 are able to generate bona fide iPS cells by inducing pluripotency
in mouse fibroblasts. We discovered that the inability of zebrafish Pou2 to induce pluripotency is not
characteristic of all teleost Pou2 genes. In fact, medaka Pou2 ortholog showed a similar potency to axolotl
Oct4.
Our data indicate that the reprogramming ability to a pluripotent cell state is an ancient trait of Pou2 and
Oct4 homologs.
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Figure 9: Expression of endogenous pluripotency markers and teratoma assay of mouse iPS
cells which were generated by applying the different POU factors
(A) Expression of endogenous pluripotency markers was measured by qRT-PCR in two clonal iPS cell lines
(#1, #2 or #3) established applying one of the various POU factor, in two mES cell lines and in MEF.
All data are calibrated to mES cells #1, which is defined as 1 and thus plotted relatively to the mES cells
#1. Error bars reflect the standard error mean based on replicates. (B) Teratoma assay of mouse iPS cells.
Nude mice were injected subcutaneously with mouse iPS cells generated using the different POU factors.
Four weeks later sections of generated teratomas were stained with hematoxylin and eosin and showed all
three embryonic germ layers: endoderm (e... respiratory epithelium), mesoderm (c... cartilage, m... skeletal
muscle, f... adipose tissue), ectoderm (n... neural epithelium with rosettes, p... pigmented melanocytes).
Experiments were performed by the collaborating group of Scho¨ler.
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6.2.8 Axolotl Oct4, Pou2 and Sox2 reprogram human fibroblasts
Axolotl Oct4 and Pou2 had the potential to generate iPS cells from mouse fibroblasts. Hence, we wanted to
characterize the pluripotent network in more detail in an in vitro study by applying axolotl Oct4, Pou2 and
Sox2 to human fibroblasts, an evolutionary advanced cell type.
In mammalian ES cells Oct4 and Sox2 activate target pluripotency genes and both are essential genes to
induce pluripotent stem cells (Yamanaka, 2007). Thus as positive control for our in vitro reprogramming
assay in human fibroblasts we used the mammalian factors Oct4, Sox2, Klf4 and with or without c-Myc.
To test the pluripotent character of the axolotl Oct4, Pou2 and Sox2 we exchanged the human factors and
replaced them by one or two factors from the axolotl. The tested combinations are summarized in Table 1.
Table 1: Tested combinations to reprogram human fibroblasts
Abbreviation Factors
OSK human Oct4, Sox2, Klf4
OSKM human Oct4, Sox2, Klf4, c-Myc
osK axolotl Oct4, Sox2, human Klf4
oSK axolotl Oct4, human Sox2, Klf4
OsK human Oct4, axolotl Sox2, human Klf4
osKM axolotl Oct4, Sox2, human Klf4, c-Myc
oSKM axolotl Oct4, human Sox2, Klf4, c-Myc
OsKM human Oct4, axolotl Sox2, human Klf4, c-Myc
pSK axolotl Pou2, human Sox2, Klf4
pSKM axolotl Pou2, human Sox2, Klf4, c-Myc
Retrovirus encoding for the different factors was used to transduce two primary human fibroblast cell lines:
hFib # 1 and hFib #2 (Figure 10) and thus to generate human iPS cells, termed as iPS #1 and iPS #2,
respectively. We were able to establish iPS cells from all tested combinations (Table 1). A representative
iPS colony which was generated with axolotl factors Oct4 (o), Sox2 (s) and human Klf4 (K) is illustrated in
Figure 10. The cell morphology shows a high similarity to the the human ES cell line H9 and to the iPS cells
generated with only human factors (OSK).
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hFib #1 H9 hES cells iPS #1 osK2 iPS #1 OSK
Figure 10: Generation of human induced pluripotent stem cells achieved by applying axolotl
Oct4 and axolotl Sox2
Panel illustrates an iPS cell colony generated by applying axolotl Oct4 (o), Sox2 (s) and human Klf4 compared
to the negative control, the initially used human fibroblasts (hFib #1). Positive controls were the human ES
cell line H9 and the iPS cells generated with only human factors (OSK). Scale bars 100 µm. Experiments
were performed by the collaborating group of H. Scho¨ler.
6.2.9 Characterization of molecular properties of human iPS cells generated by axolotl Oct4,
Pou2 and Sox2
All generated iPS colonies were genotyped by PCR and we could verify the presence of only the applied
transgenes. Figure 11 A shows genotyping of iPS cells generated with axolotl Oct4 whereas Figure 11 B
illustrates the genotyping result from iPS cells induced by axolotl Pou2.
The next step was the investigation of the expression of different pluripotency markers in the generated iPS
cell. Therefore, we performed an immunochemical staining. Generated iPS cells using axolotl Oct4 and Sox2
(Figure 12 A) or Pou2 (Figure 12 B) were stained for the pluripotency markers OCT4, NANOG, the stage-
specific embryonic antigen 4 (SSEA4), and the ES cell markers TRA1-60 and TRA1-81. All of them showed
a similar expression intensity as in the human ES cell line H9 and the iPS cells generated with the human
factors Oct4 (O), Sox2 (S) and Klf4. iPS cells did not stain for the non-pluripotency marker stage-specific
embryonic antigen 1 (SSEA1) (Figure 12 A). Human fibroblasts did not stain for the various pluripotency
markers.
Next, we measured the mRNA levels of the endogenous pluripotency markers Oct4, Sox2, Klf4, c-Myc,
Nanog, Lin28, Rex1 and Dppa4 in the generated iPS cells and compared levels to the initial fibroblast cell
population and two ES cells lines (Shef3, NCL4), the positive controls. The iPS cells were generated using
axolotl Oct4 and Sox2 in combination with the human factors, and the analysis was performed by quantitative
RT-PCR and plotted relatively to Shef3 in Figure 13 A. Figure 13 B shows the relative expressing levels in
iPS cells generated with axolotl Pou2 in combination with the human factors. We could show that iPS cells
generated with different sets of factors have a similar expression level of pluripotency markers as ES cells.
However they are dramatically different when compared to the levels obtained from the human fibroblasts
cell line.
Further, we performed microarray analysis to study global gene expression profiles of different iPS cell lines
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Figure 11: Genotyping of human induced pluripotent stem cells achieved by applying axolotl
Oct4, Pou2 and Sox2
(A) Genotyping of human iPS cell colonies induced by axolotl Oct4 and/or axolotl Sox2 and (B) axolotl
Pou2 in combination with the human factors. Genomic PCR was performed with specific primers for each
viral vector. DPPA4 was considered to be a loading control, hFib #1 was the negative control, while (A)
iPS #1 generated with only human factors Oct4 (O), Sox2 (S), Klf4 (K) and c-Myc (M) or (B) plasmid used
in viral preparation were used as positive controls. Experiments were performed by the collaborating group
of H. Scho¨ler.
and compared it to profiles from human fibroblasts and human ES cell lines. In pairwise scatter plots we
compared iPS1 osK2 cell line with the initial hFib #1 population (Figure 13 C) and the human ES cell
line Shef3 (Figure 13 D). We can demonstrate that hFib #1 osK2 cells exhibit a fully reprogrammed gene
expression profile which is very similar to Shef3 but distinct from that of hFib #1 cells.
Activation and inactivation of genes is regulated due to demethylation or methylation, respectively of the
promoter region of a gene. To investigate whether the promoter of pluripotency genes was activated or not we
performed bisulfite sequencing analysis of the Oct4 and Nanog promoter regions (Figure 13 E). We detected
demethylation and thus an activation of both promoters during the reprogramming process in iPS cell. In
comparison, the parental hFib #1 population is highly methylated in Oct4 and Nanog promoter region.
We also performed a hierarchical analysis of generated iPS cells, human ES (hES) cells and parental human
fibroblasts based on gene expression profiles. We observed a clustering of diverse hES cells with iPS cells
generated with a different set of factors on the same tree branch. However, this group can be distinguished
clearly from human fibroblasts (Figure 13 F).
These results suggest that axolotl Oct4 and Pou2 are able to reprogram the fibroblast transcription network
and generate a de novo pluripotent cell state.
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Figure 12: Immunofluorescence staining of the pluripotency markers in induced pluripotent
stem cell
(A) Immunofluorescence staining of the pluripotency markers NANOG (red), OCT4 (red), SSEA4 (red),
TRA1-60 (red) and TRA1-81(red) in the various iPS cells lines generated using axolotl or human Oct4 and
Sox2. The human ES cell line H9 and iPS cell line generated with human factors Oct4 (O), Sox2 (S),
Klf4 (K) were used as positive controls. Non-pluripotency marker SSEA1 does not show a staining. (B)
Immunofluorescence staining of the pluripotency markers OCT4 (red), NANOG (red), SSEA4 (red) TRA1-60
(red) and TRA1-81(red) in the various iPS cells lines generated using axolotl Pou2. Human Fib #1 were
considered as the negative control. Nuclei were counterstained with Hoechst (blue). Scale bars 500 µm.
Experiments were performed by the collaborating group of H. Scho¨ler.
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Figure 13: Molecular characterization of human induced pluripotent stem cells
Expression of the endogenous pluripotency markers Oct4, Sox2, Klf4, c-Myc, Nanog, Lin28, Rex1 and Dppa4
in human ES cells, human fibroblasts hFib #1, hFib #2 and iPS cells using (A) axolotl Oct4 and Sox2 or
(B) axolotl Pou2 in combination with the human factors was determined by qRT-PCR and plotted relative
to hES cell levels. Error bars indicate standard errors based on normalization to GAPDH and ACTB. (C),
(D) Illustrate a pairwise scatter plots of global gene expression profiles comparing iPS #1 osK2 cells with
(C) hFib #1 cells and (D) Shef3 hES cell line. Black lines label a two-fold change in gene expression between
paired populations. Color code on the right marks scattering density. Up- and down-regulated genes are
shown by red and green dots, respectively. The position of the pluripotency markers Oct4, Sox2, Nanog,
Klf4, Lin28 and c-Myc is represented as orange circles. (E) Bisulfite sequencing of genomic Oct4 and Nanog
promoter regions in iPS #1 osK1, iPS #1 osKM1, iPS #2 osKM1 compared to human fibroblasts hFib #1.
White and black circles display unmethylated and methylated CpGs, respectively. (F) Hierarchical clustering
based on gene expression profile. Blue branches connect human fibroblasts and red branches connect iPS cells
or human ES (hES) cells, both pluripotent cell populations. Experiments were performed by the collaborating
group of H. Scho¨ler.
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6.2.10 Generated induced pluripotent stem cells are pluripotent
Further, we evaluated the pluripotent potential of the generated iPS cell lines. We performed in vitro studies
on embryoid body formation using the hanging-drop method. Cells were induced to differentiate. To deter-
mine whether the specific cell types of all three germ layers were formed, we carried out immunofluorescence
staining two weeks after induction. We observed a positive immunofluorescence staining for the endoderm
marker α-FEROPROTEIN, the mesoderm marker α-SMOOTH MUSCLE ACTIN and the ectoderm marker
βIII TUBULIN in the generated cells. This indicates that the iPS cells generated using axolotl Oct4 and
Sox2 in combination with mammalian Klf4 and with or without c-Myc (Figure 14 A), as well as iPS cell
generated with axolotl Pou2 and mammalian Sox2 and Klf4 and with or without c-Myc (Figure 14 B) have
a pluripotent potential.
The in vivo differentiation potential of iPS cells generated using axolotl Oct4 was studied by teratoma
formation, a classical method for measuring the pluripotency of human ES cells. Therefore nude athymic
mice were subcutaneously injected with iPS cells and 6 to 8 weeks later we analyzed whether all three germ
layers had formed. Hence we did a hematoxylin and eosin staining on microsections. We observed teratoma
formation from all lines analyzed (Figure 15). Teratomas contained respiratory epithelium from endoderm,
cartilage and skeletal muscle formed from mesoderm and neural epithelium differentiated from ectoderm.
Our results indicate that iPS cell lines can be generated from fibroblasts of two different mammalian species
using axolotl Oct4 and axolotl Pou2. Furthermore, the generated iPS cells feature a pluripotent ability to
differentiate into cells of the three germ layers - ectoderm, mesoderm and endoderm.
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Figure 14: In vitro differentiation of human iPS cells generated using axolotl factors
Human iPS cells differentiated in vitro into cells of all three germ layers. iPS cells were stained by immuno-
cytochemistry. α-FEROPROTEIN (AFP) was used as endodermal marker, α-SMOOTH MUSCLE ACTIN
(SMA) as mesoderm marker and βIII TUBULIN (TUJ1) as ectoderm marker. All markers are shown in red
whereas nuclei were counterstained with Hoechst and are illustrated in blue. Scale bars 250 µm. Experiments
were performed by the collaborating group of H. Scho¨ler. (A) In vitro differentiation of human iPS cells
generated with axolotl Oct4 and Sox2 in combination with mammalian Klf4 and with or without c-Myc. (B)
In vitro differentiation of human iPS cells generated with axolotl Pou2 and mammalian Sox2 and Klf4, and
with or without c-Myc.
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Figure 15: In vivo pluripotency analysis of the human iPS cells
Nude mice were injected with iPS cells generated using axolotl factors (Oct4 (o), Sox2 (s)) plus human
factors (Klf4 (K), c-Myc (M)). Images show microsections of hematoxylin and eosinstained teratoma after
6 to 8 weeks. Generated iPS cells have differentiated into tissues of all three germ layers: endoderm (e...
respiratory epithelium), mesoderm (c... cartilage, m... skeletal muscle), and ectoderm (n... neural epithelium
with rosettes). Experiment was performed by the collaborating group of H. Scho¨ler.
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6.3 Discussion
6.3.1 Evolution of POU homologs
The evolution of the ancestral class V POU gene and thus Oct4 had been discussed controvertibly in the
past years (Frankenberg et al., 2010; Niwa et al., 2008). In our study, we could show for the first time that
axolotl, a basal tetrapod, retained both POU homologs, the POU2 and the OCT4, during evolution. So
far, this had been only observed in marsupials and monotreme mammals (Frankenberg et al., 2010; Niwa
et al., 2008). Xenopus laevis on the other hand contains three different Oct genes, which are referred as Pou
genes (Pou25, Pou60, Pou91) in this thesis (Cao et al., 2006), but no Oct4, whereas humans have two splice
isoforms of OCT4 (Atlasi et al., 2008) but do not harbor a Pou gene.
Phylogenetic assembly of POU domains from different species showed a division of class V POU factors
into OCT4 and POU2. In xenopus the POU class V ancestor gene duplicated in evolution, resulting in the
different POU orthologs Pou25, Pou60 and Pou91.
Axolotl POU2 shows similarities to the POU2 sequences in chicken and tammar, but it is evolutionary further
distinct from zebrafish POU2. On the other hand, axolotl OCT4 clusters with sequences from lizard, tammar
and different eutherian mammals like mouse. Our results indicate that axolotl Pou2 and Oct4 are clearly
distinguishable genes. From the results of the phylogenetic, synteny analyses and the different expression
pattern of Oct4 and Pou2 we claim that Pou2 from axolotl is a bona fide Pou2 and thus does not belong to
the Oct4 family.
Based on our result of the phylogenetic assembly of POU domains from different species we confirmed
Frankenberg et al. (2010) hypothesis of an ancestral class V POU gene duplication latest in early tetrapod
development.
The POU domain gene from Hydra seems to have characteristics of an Oct4/Pou2 precursor gene (Millane
et al., 2011) which would suggest that OCT4/POU2 ancestral proteins had been present already before the
evolutionary development of vertebrates.
6.3.2 Axolotl Oct4 and Pou2 are both expressed in pluripotent cell types and germ cells
The mRNA of axolotl Pou2 and Oct4 both showed a pattern in the ectoderm of gastrula stage embryos.
Furthermore, we observed that the mRNA of Sox2 is consistent in localization with the mRNA of the Pou2
genes. All three genes were expressed in the animal cap region of gastrula stage embryos, a highly pluripotent
area.
Frankenberg et al. (2010) showed that Oct4 as well as Pou2 are present in pluripotent tissues of tammar.
OCT4 was expressed in gastrula stage tammar embryos whereas POU2 was present in the primitive streak
stage conceptus.
These results suggest that axolotl and marsupial Pou2 is associated with pluripotent cells of the gastrula,
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and similar to Oct4 from both species (Frankenberg et al., 2001).
Tammar OCT4 was expressed in oocytes, proliferating oogonia, and migrating germ cells. They further
examined the mRNA pattern of Oct4 and Pou2 in different tissue types of the tammar and identified an
intensive Oct4 expression in developing testis cords, the germ cells. However, Pou2 mRNA was not detectable
(Frankenberg et al., 2010).
Zebrafish Pou2 does also not show an expression in developing primordial germ cells or the adult gonads
(Marlow and Mullins, 2008).
In contrast, it had been reported that medaka expresses Pou2 during embryonic development but also in
primordial germ cells, in the male germ cells the spermatogonia, in adult testis and in oocyte development
(Sanchez-Sanchez et al., 2011, 2010). However, its function remained unclear. Since medaka does not have an
Oct4 homolog one could assume that medaka Pou2 has a post-embryonic function in germ line development.
In axolotl, Bachvarova et al. (2004) could not detected Oct4 expression in primordial germ cells. However,
our observations would indicate that axolotl Oct4 and Pou2 are expressed in primordial germ cells.
Interestingly, this pattern of Oct4 and Pou2 gene retention in different organisms correlates with the variable
mechanisms of germ cell formation found among vertebrates. Fish, xenopus and chicken retained Pou2. In
these organisms germ cell formation is determinative, meaning that germ cells are generated through the
segregation of germ plasm. In contrast, axolotl and mammals retained Oct4. Here, the germ cell formation is
inductive, meaning that germ cells are formed by induction of embryonic mesoderm (Johnson et al., 2003a,b).
Axolotl is the first species described which harbors both Oct4 and Pou2, and both are not only expressed
in the pluripotent animal cap of gastrula stage embryos but also in primordial germ cells. Our observations
imply that the ancestral Oct4/Pou2 gene could have played a role in pluripotency as well as in germ cell
development. This ability was selectively lost in some species during evolution.
6.3.3 Conservation and diversification of POUV proteins
By in vitro studies we demonstrated that the Oct4 and Pou2 gene from axolotl can confer pluripotency.
Surprisingly, we could show that both can confer pluripotent character and can reprogram fibroblasts from
two different species, mouse and human, to generate a pluripotent cell.
In our mouse fibroblast reprogramming assay we were not able to establish iPS cell colonies using zebrafish
Pou2. Even so we observed GFP-expressing cells after transduction. This data is strengthened by the fact
that zebrafish Pou2 is not able to maintain ES cell character when mouse Oct4 is absent (Niwa et al., 2008;
Morrison and Brickman, 2006). It had been shown that zebrafish Pou2 has a function as a mediator of
endoderm induction and differentiation during gastrulation (Lunde et al., 2004). However, the restricted
induction potential of zebrafish Pou2 does not apply for all Pou2 orthologs since axolotl POU2 as well as
medaka POU2 can induce pluripotent stem cells. Furthermore, using mouse fibroblasts, xenopus POU91
showed highly efficient reprogramming potential similar to the mammlian factors from mouse and human
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(Figure 10 B).
In Xenopus laevis three POU homologs have been identified, Pou25, Pou60 and Pou91. At that time no
self-renewing ES cell lines have been generated from lower vertebrate species. Thus, it was unknown whether
the mechanisms governing self-renewal were conserved. As the Oct4 gene is an essential requirement for ES
cell self-renewal, Morrison et al. assayed the ability of the different POU family members to substitute for
Oct4 by using an inducible Oct4 knockout ES cell line (Morrison and Brickman, 2006). In ES cells both
alleles of the endogenous Oct4 had been inactivated, and thus OCT4 expression in these cells is maintained
by a Oct4 transgene. They assessed the OCT4 rescue by measuring alkaline phosphatase positive ES cell like
colonies, the long-term self-renewal, and the expression of ES cell specific markers. They demonstrated that
POU91 has the ability to maintain murine ES cells in the absence of Oct4. Xenopus POU25 and POU60
as well as axolotl OCT4 had some ability to rescue ES cell self-renewal (Morrison and Brickman, 2006).
These data suggest that ES cell self-renewal is a conserved aspect of vertebrate Oct4/Pou2, rather than
mammalian-specific.
Axolotl is an organism containing the three transcription factors Oct4, Pou2 and Sox2. It is known that
induction of mammalian adult fibroblasts to generate iPS cells requires Oct4 and Sox2 (Takahashi and
Yamanaka, 2006). We are the first group to replace the mammalian with axolotl factors and investigating
the reprogramming potential of human fibroblasts. We showed a pluripotency-related role for axolotl Sox2.
POU2, OCT4 and/or SOX2 expression combined with the human factors generated iPS cells from human
fibroblasts. This indicates that the axolotl factors do not only substitute human homologs, but can also
dimerize with the human proteins.
To summarize, axolotl Oct4 but also axolotl Pou2 were able to reprogram human and mouse fibroblasts. This
would propose that already the ancestral class V POU gene possessed a pluripotency conferring potential and
this characteristic also remained after the duplication of class V POU at the base of tetrapod development.
Thus, pluripotent potential is a feature for Pou2 as well as for Oct4. However, at some point in evolutionary
history the pluripotency conferring potential of Pou2 expression in zebrafish disappeared while it retained
and/or gained functions in somatic cells (Morrison and Brickman, 2006; Niwa et al., 2008).
6.3.4 Summary I
Finally, with our study we show the first time that axolotl contains both POU homologs, the already identified
Oct4 (Bachvarova et al., 2004) but also Pou2. Axolotl Pou2, Oct4 and Sox2 mRNA was localized in the
pluripotent animal cap region of gastrula stage embryos. Furthermore, Pou2 and Oct4 was also present in
primordial germ cells. Further we demonstrated that axolotl Pou2, Oct4 and Sox2 together with human
factors are able to induce pluripotency in mouse and human fibroblasts. Thus, axolotl factors can substitute
their mammalian homologs and in addition, are also able to form heterodimers with the mammalian proteins.
With these observations, we are the first group to identify the role of axolotl Sox2 expression in a pluripotency
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related context. This means that human and axolotl Oct4 and Sox2 have a conserved activity in inducing
pluripotency which suggests a highly conserved pluripotency network, and thus induced pluripotency is
characteristic not only occurring in mammals, but existed already in the Oct4/Pou2 common ancesteral
vertebrates.
Intraspecies cell reprogramming has already been investigated (Huangfu et al., 2008b; Wu et al., 2009).
However, here we show the first time that human somatic cells can be also reprogrammed with Oct4 and
Sox2 from lower vertebrates.
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7 Chapter II: Regenerating spinal cord cells are pluripotent
7.1 Introduction
7.1.1 Advantages of regeneration studies on salamanders
Most investigations in regenerative biology aiming a medical application have focused on in vitro studies on
stem cells. However, to have a firm understanding of regenerative processes, in vivo studies are inevitable.
Thus, one can study complicated interactions taking place between different cell types. The usage of model
organisms is essential to provide the knowledge, and to eventually understand, manipulate and control regen-
erative properties. Understanding the regenerative mechanisms is potentially advantageous for biomedicine
and future medical treatments in humans by stimulating regeneration through endogenous pathways.
It is known that some adult non-mammalian vertebrates have the potential to fully regenerate lost tissue
structures in a process termed epimorphic regeneration (Brockes, 1997).
Tail regeneration in salamander might represent a natural example where differentiated somatic cells are
efficiently reprogrammed to a stem cell like state. Thus, it would be interesting to study this process in vivo.
Due to its enormous regeneration potential, salamanders like Ambystoma mexicanum became a very attractive
regeneration model organism in the past decades. Animals can be kept and breed in colonies. Due to relatively
low maintenance costs it is possible to raise a large number of animals. One mating can yield about 200 -
400 offspring. Furthermore, axolotl larvae are transparent and thus perfect for techniques like live imaging.
In addition, they have a relatively short regeneration time, depending on temperature and size of the animal.
In this study, we were interested in the involved genes in pluripotency during regeneration. Comparing
most gene sequences it was depicted that salamander sequences show higher similarity to xenopus than to
mouse sequences. However, axolotl OCT4, as one pluripotency factor and other germ-cell associated protein
sequences are more similar to mammals than to POU sequences in xenopus (Johnson et al., 2003a; Bachvarova
et al., 2004).
In the last years, progress in molecular biotechnology and manipulations of the animal positions the axolotl
as an excellent regeneration model organism. Tools like expressed sequence tags, which are used to identify
gene transcripts, became available for axolotl (Habermann et al., 2004). We further developed an efficient
transgenesis protocol for axolotl (Sobkow et al., 2006). Thus, we were able to label specific cell and tissue types
and to follow gene expression in the cells of interest. Transgenic animals contain site-specific recombination
sites which is necessary to turn on gene expression in either a tissue-dependent, or time-dependent manner
by controlling expression of the Cre recombinase.
7.1.2 Lens regeneration in amphibians
Newts and frogs are able to regenerate the eye lens, but salamanders lost this ability. While lens regeneration
in frogs only occurs before metamorphosis using cornea epithelium cells, the regenerative process in newts
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takes place throughout their adult life from dorsal iris pigment epithelial cells (PEC) (Watanabe, 1978). The
ventral iris PEC has no lens regeneration ability.
Hayashi et al. (2004) showed that the fibroblast growth factor FGF2, a protein functioning in initiating the
regeneration process, induces expression of the transcription factor genes Pax6 and Sox2. During normal lens
regeneration, the transcription factor genes Sox2 and Klf4 are upregulated two days after injury, a time point
when pre-existing tissues become reprogrammed and re-enter the cell cycle (Maki et al., 2009). In contrast,
c-Myc peaked at day eight after injury, a time point when the vesicle formation is establishing (Maki et al.,
2009). OCT4 and NANOG were not expressed in the PEC during regeneration (Maki et al., 2009). Based
on the expression profile, the researchers hypothesize that the newt cells do not become pluripotent.
Ito et al. (1999) performed regeneration studies by transplanting iris PEC into limb. They dissociated iris
PEC and transplanted reaggregates of dorsal and ventral iris PEC into blastema of forelimb in newt. Lens
was formed in high efficiency from dorsal PEC, in a process similar to normal lens regeneration. Ventral iris
PEC on the other hand did not regenerate a lens. In addition, when reaggregates were transplanted into
non-regenerating limb no lens was formed. They showed that the dorsal cells are only able to form lens.
Hence, the newt cells are not pluripotent (Ito et al., 1999). The transdifferentiation process is restricted.
7.1.3 The development of the vertebrate tail
The vertebrate tail is a post-anal extension along the main body axis and includes a neural tube and a noto-
chord which is surrounded by somitic mesoderm. There were two different views about the tail development
discussed amongst embryologists. The old hypothesis proposed that the tailbud develops by a blastema-like
mass of mesenchymal cells (Holmdahl, 1925). After new studies were undertaken this hypothesis seems less
likely. The alternative view point is that the tail arises by morphogenic processes which also shape the head
and trunk during gastrulation.
To establish the bilateral symmetry of an organism, the site of gastrulation and the initiation of germ layer
formation the presence of the primitive streak is necessary. The primitive streak is a structure that develops
in the early avian, reptilian and mammalian embryo. The epiblast has polarized epithelial cells, which are
connected to mesenchymal cells (area opaca) in the periphery, able to form extra-embryonic tissue. The inner
cells (area pellucida) will give rise to the embryo (reviewed in Chuai and Weijer (2009)). Area opaca and area
pellucida are separated by epithelial cells, the marginal zone. An aggregate of cells underneath the epiblast
is formed at the posterior pole of the area pellucida. Mesendoderm starts forming from epiblast cells, and
moves towards the midline of the embryo generating the primitive streak. The midline is the first embryonic
axis established, and is the the beginning of gastrulation. The streak is formed at the posterior pole of the
epiblast and then elongates towards anterior. When it is about halfway over the epiblast, cells deeper in the
streak move between epiblast and hypoblast to build gut, muscles, and skeleton. In chicken, Pou2 mRNA
was localized in the epiblast of pre-primitive streak stage embryos and the later formed hypoblast. When the
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Figure 16: Scheme of xenopus tailbud development shown as sagittal section
(A) Tailbud develops after gastrulation (stage 13) by interaction of the notochord and the posterior neural
plate. (B) In early tailbud stage (stage 22) the lateral blastopore lip grows over the blastopore and forms
the posterior wall. The iniciated neuroenteric canal continues the neural tube lumen. (C) Magnification
of posterior area ”B”. Positions of N (neural plate anterior to M), M (most posterior neural plate) and C
(caudal notochord) regions form the tailbud. Picture from Beck and Slack (1998).
primitive streak forms, chicken Pou2 was detected in the epiblast of the streak itself and the mesendoderm
(Lavial et al., 2007b). Whole mount in situ hybridisation on mouse embryos showed that Sox2 mRNA was
present in the primitive streak ectoderm and gut endoderm (Wood and Episkopou, 1999). Wilson et al. (2009)
showed that the streak marker FGF8 was also expressed in the primitive streak and the tailbud (Cambray
and Wilson, 2002; Chapman et al., 2002; Goﬄot et al., 1997) of mouse and chick embryos. FGF4, an early
embryonic developmental marker, is also expressed exclusively in the primitive streak during gastrulation.
It was reported that a protein complex including OCT4 and SOX2 regulates FGF4 expression (Ambrosetti
et al., 1997; Dailey et al., 1994).
Fate map studies showed that the mechanism of tail formation is highly conserved between different verte-
brates (Tucker and Slack, 1995b; Kanki and Ho, 1997; Catala et al., 1995). The tailbud is assumed to be a
mosaic cell population with their origin more anterior in the embryo. The tailbud is a direct derivative of
the late blastopore lip and has an organizer like property, attracting cells into the axis (Gont et al., 1993;
Tucker and Slack, 1995a). Tailbud formation starts after gastrulation with differentiation of the germ layers
by an interaction of the notochord and the posterior neural plate (Figure 16 A). The chordoneural hinge,
a direct derivative of the late dorsal blastopore lip assists the formation of tail notochord and spinal cord
(Tucker and Slack, 1995b), (reviewed in Handrigan (2003)). Later the posterior wall forms due to covering
the neural tube over the blastopore (Figure 16 B). Chordoneural hinge and the posterior wall are separated
by a neurenteric canal (Gont et al., 1993). Tucker and Slack (1995b) proposed the ”NMC” model (Figure 16
C), which means that the tailbud formation requires a junction of the posterior neural plate (M), neural plate
anterior to ”M” (N) and the caudal notochord (C). Clonal analysis showed that myotomes and cells of the
central nervous system (CNS) derive from a stem cell population (Mathis and Nicolas, 2000; Nicolas et al.,
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1996). It was reported that the chordoneural hinge represents at least one stem cell population which gives
rise to notochord and ventral spinal cord, and the posterior wall forms somites (Gont et al., 1993; Cambray
and Wilson, 2002, 2007; McGrew et al., 2008), (also reviewed in Handrigan (2003)).
Recent studies analyzed the progression of lineage segregation during embryogenesis in mice (Tzouanacou
et al., 2009). They identified common progenitors for neural and mesodermal (N-M) lineages in the tailbud
stage. These N-M progenitors supply derivatives to both tail tissues (Tzouanacou et al., 2009). Cells in the
chordoneural hinge give rise to the neural tube, notochord and somites (Beck and Slack, 1998; Cambray and
Wilson, 2002; McGrew et al., 2008).
Tzouanacou et al. (2009) results in mouse challenged the idea that there is a closer interaction between
neurectoderm and mesoderm than between surface- and neural ectoderm. Interestingly, Downs (2008) de-
tected OCT4 expression in mouse after gastrulation until the 16-somite stage. At headfold stage OCT4
expression was detected in the surface- and neural ectoderm of caudal node in mouse, the anterior end of the
primitive streak formed in early gastrulation (Downs, 2008). Studies reported that the ventral node in mouse
contains cells able to self-renew (Beddington, 1994; Tam et al., 2004). Fate map studies of chick Hensen’s
node indicated that different parts of this complex structure give rise to multiple cell lineages like ectoderm
or neural tube (Selleck and Stern, 1991).
These findings suggest that the OCT4 expressing caudal node may be a stem cell reservoir.
7.1.4 Regeneration of the tail in axolotl
Regeneration of the tail in salamanders like the axolotl is categorized in the three steps: (i) wound healing,
(ii) blastema formation and (iii) regenerative outgrowth.
Figure 17 A shows a non-amputated fully functional tail. (i) Once the tail is amputated (Figure 17 B)
wound closure takes place soon after, and cells from the surrounding epidermal tissue cover the amputation
stump. This leads to migration of proximal cells towards the amputation plane and (ii) within the first days
a blastema is formed (Figure 17 C).
Previously, it was thought that blastema cells are undifferentiated reprogrammed pluripotent cells and thus
they would be able to form each cell type. However, in limb regeneration studies it was shown that blastema
cells are a heterogenous mixture of cells which ”remember” their origin and hence are limited to their lineage
in regeneration (Kragl et al., 2009). It could be that blastema cells in regenerating tail have a similar
characteristic.
In mouse development, OCT4 was expressed in the ectoderm of the caudal node, the anterior end of the
previously formed primitive streak (Downs, 2008). It would be interesting to know whether OCT4 is also
expressed in regeneration of the axolotl tail, and hence the blastema cells would be in an ES cell-like state.
This transient structure of undifferentiated and proliferating blastema cells gives rise, in an origin dependent
manner, (iii) to the different cell types necessary for the newly formed tail. Over the following days the
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outgrowth of the regenerate takes place (Figure 17 D, E) until a fully functional tail is visible (Figure 17 F).
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Figure 17: Regeneration of an axolotl tail over time
(A) Fully functional tail before amputation. (B) Amputation. (C) Within the first day after amputation
a formation of undifferentiated and proliferating blastema cells, recruited from the mature tissue part, is
visible. (D, E) Over the next days an outgrowth of the regenerating tail takes place until it has its (F)
complete structure formed. Dashed line illustrates the amputation plane. (Picture adopted from Tanaka).
7.1.5 Regeneration of the spinal cord in axolotl tail
The spinal cord in the tail is the most accessible part of the vertebrate CNS and the structure is simpler
than for example the complex structure of the brain. Due to these reasons, it is relatively easy to study.
Like any other vertebrate, the spinal cord in axolotl is composed of grey matter in the central core which is
surrounded by white matter.
In Figure 18 it is illustrated that irrespective of where the tail together with the spinal cord is amputated, cells
in a 500 µm zone proximal of the amputation plane are recruited to regenerate the missing part (McHedlishvili
et al., 2007).
We identified this by transplanting EGFP expressing spinal cord into a non-GFP host where the spinal cord
was removed (Figure 18 A, D). Tail was amputated leaving 600 µm (Figure 18 B) and 350 µm (Figure 18 E)
remaining. At day 16 of regeneration we observed an entirely regenerated spinal cord derived from EGFP
expressing cells when 600 µm was remaining (Figure 18 C). In contrast, only a portion of the spinal cord was
EGFP expressing when leaving only 350 µm in the amputation stump remaining (Figure 18 F).
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Figure 18: A zone of 500 µm in the mature spinal cord provides progenitor cells necessary in
the regeneration process
A spinal cord section of 4 mm from an EGFP expressing transgenic animal was transplanted into a wild
type 3.5 cm host. (A, D) axolotl tail harboring an implanted EGFP transgenic spinal cord 7 days after
transplantation. Tail was amputated illustrated by the dashed line leaving an EGFP expressing spinal cord
of (B) 600 µm or (E) 350 µm remaining in the host. (C) Tail at 16 days of regeneration. Entire regenerated
spinal cord is derived from EGFP expressing cells. (F) On day 16 only about 70% of regenerated spinal cord
is formed from EGFP expressing cells. Scale bar 2 mm. (Figure adopted from (McHedlishvili et al., 2007))
The cells in the 500 µm zone proximal of the amputation plane have the status of progenitor cells. They
increase their cell division and form an elongating neuroepithelial tube, also termed ependymal tube. The
ependymal cell layer lining along the central channel of the spinal cord plays an important part in the spinal
cord regeneration (Ferretti et al., 2003; Chernoff et al., 2003; Holder and Clarke, 1988). These cells provide
neural progenitors needed in the process.
Upon amputation, the ependymal tube grows out of the cut spinal cord into the blastema. Ependymal cells
proliferate, migrate and eliminate extracellular matrix and cell debris from apoptotic cells (Egar and Singer,
1972). Cells at the distal end of the growing ependymal tube form a terminal vesicle. The cells can leave the
terminal vesicle and migrate into the blastema.
During spinal cord regeneration there is also axonal growth taking place. In injured animals, ependymal cells
express early neural markers like vimentin and nestin, which was undetectable in non-injured urodele spinal
cord (O’Hara et al., 1992; Walder et al., 2003). Furthermore, studies with Bromodeoxyuridine (BrdU) were
performed to investigate ependymal cells in the regenerate. BrdU, a synthetic nucleoside, is an thymidine
analogue and is used to label and detect proliferating cells. Thus, in vivo and in vitro studies showed that
BrdU labeled ependymal cells give rise to glia cells and neurons in adult newt (Benraiss et al., 1999). As
well as functional replacement of spinal cord with their axons, cellular regeneration such as renewal of motor
neurons is taking place. It was shown that motor neurons can be also formed in a postembryonic stages.
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They occurred relatively often in small (5-7 cm long) axolotls, but only occasionally in large (7-13 cm long)
animals (Holder et al., 1991; Arsanto et al., 1992).
7.1.6 Neurogenesis is not restricted to embryonic development
In the past it was believed that neurogenesis in CNS of mammals was limited to embryonic development
and the early postnatal period, and hence in the adult would not regenerate after an injury (y Cajal, 1928).
The inability of mammalian CNS to induce axonal growth and thus to regenerate was concluded from
the following observations: in CNS myelin and injury-induced glia scars at the injured site, as well as in
denervated axonal tracts (Okano et al., 2003), there is an inability of endogenous neural stem cells in spinal
cord to activate de novo neurogenesis after an injury (Johansson et al., 1999) and insufficient factors to form
a trophic environment (Widenfalk et al., 2001). New research articles however revised Cajal’s dogma and
showed that axons are able to regenerate when there is an adequate environment at the site of injury. This
was shown by transplanting peripheral nerves (Richardson et al., 1980) and fetal spinal cord (Bregman, 1987)
into the injured site of the spinal cord. Later articles show that neurogenesis takes also place in adult monkey
and human brain (Eriksson et al., 1998). Further it was demonstrated that there are neural stem cells in
mature brain showing multipotency and self-renewal ability (Reynolds and Weiss, 1996, 1992; Morrison et al.,
1997). These cells are able to generate the three different cells types of the CNS: neurons, astrocytes and
oligodendrocytes (Reynolds and Weiss, 1996). Localization of neural stem cells was performed by culturing
tissue from different regions of the CNS. Stem cells could be enriched from the wall of the ventricular system
in fore- and midbrain, from the hippocampus as well as the spinal cord. The wall of the ventricular system
consists of a single ependymal cell layer in which Johansson et al. (1999) claimed that there are neural stem
cells. This is supported by a similar expression and location profile of markers like NESTIN, NOTCH 1 and
MUSASHI in ependymal cells and embryonic ventricular zone stem cells (Lendahl et al., 1990; Sakakibara
and Okano, 1997; Weinmaster et al., 1992).
In addition, ependymal cells in lizard and newt are able to generate new neurons after injury (reviewed in
Chernoff (1996)). Hence, studies of spinal cord regeneration in amphibians are a fundamental contribution
to determine requirements necessary for a successful CNS regeneration also in higher (amniote) vertebrates
like humans.
7.1.7 Fusion of cells
In the past, the fate of adult cells had been regarded as restricted to their tissue origin. However, the
observation that these cells could be reprogrammed and express differentiated cell type markers was quite
unexpected. Surprisingly, transplantation of adult bone marrow cells generated muscle cells (Ferrari et al.,
1998), liver cells (Petersen et al., 1999; Theise et al., 2000; Lagasse et al., 2000), brain cells (Brazelton et al.,
2000; Mezey et al., 2000) and others (Krause et al., 2001). Weimann et al. (2003) showed that cells of the
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human adult bone marrow contributes to cells in adult human brain. They analyzed cerebellar tissues from
female patients after bone marrow transplantation. In patients receiving male marrow, Purkinje neurons
diploid cells (Mann et al., 1978; Manuelidis and Manuelidis, 1974; Mares et al., 1973), were found which
harbor X and Y chromosome. Furthermore, there were also Purkinje neurons observed with more than a
diploid number of sex chromosomes. This would suggest that the neurons, which are only generated during
early brain development in embryogenesis, were formed from bone marrow cells. Weimann et al. (2003) claim
that the generation of Purkinje neurons takes place either de novo from marrow-derived cells or by fusion of
bone marrow-derived cells with recipient Purkinje neurons. Cell fusion has been previously suggested as a
mechanism of bone marrow contribution to tissue (Blau, 2002). Bone marrow cells could fuse with damaged
cells and provide them an intact nucleus (Weimann et al., 2003).
Barnabe-Heider et al. (2010) have assessed the origin of new cells in adult spinal cord of mice by genetic fate
mapping. They analyzed oligodendrocytes, astrocytes and ependymal cells in intact and injured spinal cord.
In the uninjured situation, ependymal cells and astrocytes are limited to self-duplication. Oligodendrocyte
progenitors on the other hand self-renew but also generate more mature oligodendrocytes. After a spinal cord
injury all three cell types are recruited. Astrocytes and ependymal cells generate the largest number of cells
and ependymal cells show multilineage potential of the progeny (Barnabe-Heider et al., 2010). However, the
researchers did not investigate how ependymal cells changed their fate. In fact they claim that the ependymal
cells are a quiescent stem cell population that is recruited after injury.
Spontaneous generation of tetraploid hybrid cells was observed in vitro when progenitor cells of the CNS
from mouse were co-cultured with pluripotent ES cells (Ying et al., 2002). ES cells used were male and
where a female fetus as brain cell source had been used, the sex chromosome complement was XXXY. This
observation can be only explained by formation of cell hybrids between ES and CNS cells. In addition, the
tetraploid cells featured a pluripotent character, including multilineage contribution to chimaeras.
Terada et al. (2002) claim that interleukin-3 plays a role in cell fusion. In in vitro studies they demon-
strated that mouse bone marrow-derived, embryonic stem-like cells fused spontaneously with ES cells when
interleukin-3 was present in culture. So far, they do not know which cell fraction in the bone marrow is respon-
sible for the fusion. Monocytes and macrophages might be involved in cell fusion. In culture, macrophages are
able to fuse spontaneously and form giant multinucleated cells (Parwaresch et al., 1986; Chiozzi et al., 1997;
Falzoni et al., 1995). In vitro studies showed that this process is enhanced by cytokines like interleukin-3
(Enelow et al., 1992).
To determine cell fate changes is challenging. Spontaneously fused cells can subsequently adopt the phenotype
of the recipient cell which could be easily misinterpreted as ”dedifferentiation” or ”transdifferentiation”.
Hence stringent analyzing criteria have to be used. Criteria for establishing the occurrence of cell fate
changes are intensively reviewed by Blau et al. (2001) and are summarized here.
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I) Demonstration that a previously silent gene specific for the new cell type becomes expressed in the cell of
interest. To observe whether proteins are co-expressed in the same cell, laser scanning confocal or deconvolu-
tion microscopy are indispensible. These methods allow analysis of optical sections less than 1 µm. Tracking
of cells needs genetic markers having non endogenous counterparts, such as GFP or the Y-chromosome when
male donor cells are introduced into female recipients.
II) Determination that the cell is well integrated into the tissue structure and thus morphologically indistin-
guishable from the host-neighboring cells.
III) Demonstration of cell fate change by a functional assay using a genetically deficient animal that is rescued
from lethality or a disease related deficit.
Taken together, cells do not usually convert directly into other cell types but rather cell fusion seems be the
mechanism used to lower the barriers between different cell identities.
7.1.8 The goal of this project
In axolotl, Oct4 mRNA is highly abundant during embryonic development until gastrulation (Bachvarova
et al., 2004), to provide a pluripotent state of the cells. Studies in mouse showed that OCT4 is even expressed
in the caudal node of embryos having 16 somites (Downs, 2008). In mouse tailbud there are progenitors giving
rise to neural and mesodermal lineage (Tzouanacou et al., 2009). This suggests that the OCT4 expressing
caudal node might be a stem cell reservoir.
Our previous in vitro study showed that axolotl OCT4, POU2 and SOX2 confer a pluripotent character and
can reprogram mammalian cells. Hence, we were interested in the involvement of the pluripotency genes
Oct4, Pou2 and Sox2 in regenerating axolotl spinal cord. We observed expression of OCT4 and SOX2 in
regenerating spinal cord cells. To determine whether the spinal cord cells have also a pluripotent character in
vivo we transplanted EGFP labeled spinal cord into somite stage embryos and showed muscle cell formation.
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7.2 Results
During embryogenesis it is known that Oct4, Sox2 and Fgf4 are present in the primitive streak and tailbud
(see chapter 7.1.3).
It had been reported, that a protein complex including OCT4 and SOX2 regulates FGF4 expression (Am-
brosetti et al., 1997; Dailey et al., 1994; Yuan et al., 1995; Pan et al., 2002).
Prior to my work A. Tazaki performed whole mount in situ hybridizations of a day-7 regenerating axolotl
tail, and determined Sox2 and Fgf4 mRNA expression pattern (Figure 19 A). Sox2 mRNA showed a strong
staining in the mature as well as the regenerating spinal cord, named also ependymal tube. Fgf4 on the
other hand was determined in the epidermis and more interestingly in the terminal vesicle, the tip of the
regenerating spinal cord with pluripotent character.
Developmental processes and regeneration share many similarities. For this reason we were interested in the
expression of the pluripotency factor OCT4 during spinal cord regeneration. In case OCT4 is expressed we
wanted to know whether the regenerating spinal cord progenitor cells have the ability to reprogram in vivo,
and thus can form a different cell type apart from neural cells.
7.2.1 Oct4, Pou2 and Sox2 mRNA are present in mature and regenerating spinal cord
Prior to my work, an axolotl blastema cDNA library was screened and Oct4 was identified. Hence, this gene
should be present in regenerating tissue. We were interested whether Oct4 together with Pou2 and Sox2
plays a role in spinal cord regeneration, and further whether the proteins confer a reprogramming capability
to spinal cord cells.
Hence, the aim of the first experiment was to examine the mRNA pattern of Oct4, Pou2 and Sox2 in non-
amputated and regenerating spinal cord using in situ hybridization. We performed cross sections through
the tail of 3 cm larvae and compared non-amputated with day-6 regenerated tails.
In non-amputated mature tails (Figure 19 B) we detected Oct4 mRNA in spinal cord and partially in
mesenchyme, whereas Pou2 and Sox2 were located in spinal cord only. In contrast to this in day-6 regenerating
tail sections (Figure 19 C) Oct4 and Pou2 were identified in spinal cord as well as blastema cells whereas Sox2
mRNA was limited to spinal cord only. Furthermore, Pou2 seemed to be upregulated in the regenerating
compared to non-amputated tail.
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Figure 19: Oct4, Pou2 and Sox2 mRNA are present in mature and regenerating spinal cord
(A)Whole mount in situ hybridization on axolotl tails collected seven days post amputation. Sox2 mRNA is
present in mature as well as in regenerating tail whereas Fgf4 mRNA is restricted to the terminal vesicle and
ectoderm. Dashed lines show the amputation plane. Scale bar 500 µm. AS = anti sense probe. Experiment
was performed by A. Tazaki. (B) In situ hybridizations was performed on non-amputated mature (n=3 each)
and (C) regenerating tails six days post amputation (n=3 each). Scale bars 100 µm. AS = anti sense probe.
(B) In non-amputated mature tail Oct4 is located in spinal cord and partially in mesenchyme, whereas Pou2
and Sox2 are restricted to spinal cord only. (C) In day-6 regenerating tail Oct4 and Pou2 are detectable in
spinal cord as well as blastema cells whereas Sox2 transcript is limited to spinal cord only.
64
7.2 Results
7.2.2 Characterization of the OCT4 antibody specificity
In addition to the determination of Oct4 and Sox2 mRNA, we were interested in the protein expression of
OCT4 and SOX2. Since there was no commercially available antibody against OCT4 working in axolotl we
had to generate them ourselves with the help of the facilities in the institute. We produced three different
polyclonal OCT4 antibodies, two against different variable regions of the C-terminus and one against the
entire highly variable N-terminus. We performed a number of immunohistochemical stainings to assess
specificity and validity of the staining pattern with the OCT4 antibodies.
To determine the specificity of the antibody, we carried out immunofluorescence stainings on sections of
gastrula stage embryos. We observed nuclear OCT4 staining in the ectoderm including the animal pole,
tissue that was shown to be positive for Oct4 mRNA (Figure 4 A).
We observed a similar staining pattern of N- and C-terminal purified antibodies but stainings using the
N-terminal OCT4 antibody (Figure 4 B) were stronger. Thus, we performed all following experiments with
OCT4 N-terminal antibody.
For a further characterization of the OCT4 antibody we performed in vitro knockdown experiments by Oct4-
morpholino. Oct4 plasmid, nuclear EGFP plasmid as electroporation control, and either standard control
morpholino or Oct4-morpholino were mixed with newt A1 myoblasts and electrically shocked to transfer
DNA and morpholino into the cells. Figure 20 A illustrates the experimental set-up. Three days later fixed
cells were stained for OCT4 with the OCT4 antibody.
We observed a strong OCT4 staining in the cells treated with standard control morpholino indicating, that the
control morpholino did not influence OCT4 overexpression in the cells (Figure 20 B). Co-electroporation of a
Oct4 plasmid and Oct4-morpholino however, reduced the OCT4 overexpression in newt A1 cells dramatically,
and was visible as a weak OCT4 staining (Figure 20 C).
Our results suggest that the N-terminal OCT4 antibody reliably detects OCT4 protein and hence could be
used for further experiments.
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Figure 20: Oct4-morpholino downregulates OCT4 overexpression in electroporated newt A1
myoblasts
(A) Experimental set-up. Newt A1 myoblasts were mixed with pCS2 Oct4 plasmid for exogenous overex-
pression of OCT4, nucEGFP as a control plasmid to determine electroporation efficiency (green) and 1 mM
of either standard control morpholino or Oct4-morpholino. Three days later cells were fixed and OCT4 ex-
pression was detected by immunostaining with a polyclonal OCT4 antibody (red). DNA was counterstained
with Hoechst 33342 (blue). (B) Strong OCT4 immunofluorescence staining (red) in the cells treated with
standard control morpholino. (C) Co-electroporation of Oct4-morpholino and Oct4 plasmid reduced OCT4
overexpression in newt A1 cells dramatically visible as a weak OCT4 staining (red). Scale bars 100 µm.
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7.2.3 OCT4 and SOX2 are expressed in non-amputated and regenerating spinal cord, with
OCT4 being upregulated in the regenerate
After detection of Oct4 and Sox2 mRNA in non-amputated and 6-day regenerating tails we also expected
OCT4 and SOX2 protein expression in these tissues. To prove that, we performed immunohistochemical
staining on sections of non-amputated and 6-day regenerating tails obtained from 3 cm larvae. We compared
the staining in proximal and distal tissue sections, with the proximal section investigating protein expression
in the mature spinal cord and the distal section the tip of the spinal cord. In samples of 6-day regenerating
tails the proximal section is about 2 mm proximal of the amputation plane and thus in a region which does
not contribute to the regeneration process. The distal section in 6-day regenerating sample however is the
regenerating tissue part and thus a major area of our interest.
In proximal sections of non-amputated tails, SOX2 was present in the dorsal root ganglion, which lies along
the spinal cord (Figure 21 A). More interestingly, SOX2 was expressed at a strong intensity in the proximal
(Figure 21 A) and similarly the distal (Figure 21 B) part of the spinal cord progenitor cells. In contrast, we
observed a low OCT4 expression in the proximal (Figure 21 C) and the distal (Figure 21 D) part of non-
amputated spinal cord sections. Further, low levels of OCT4 were detected in some cells of the mesenchyme.
Magnified images of the spinal cord in a rainbow look-up table showed the low expression levels of OCT4 at
the proximal (Figure 21 C’) and the distal (Figure 21 D’) part of the spinal cord.
In 6-day regenerating tails, SOX2 showed a strong expression similarly in the proximal (Figure 22 A) and
the distal (Figure 22 B) section of the progenitor cells in the spinal cord. OCT4 is expressed at a low level
in the proximal (Figure 22 C) region of the spinal cord. Magnified images of the spinal cord in a rainbow
look-up table showed the low OCT4 expression at the proximal (Figure 22 C’) part of the spinal cord in more
detail. The expression level is similar to non-amputated tail. In contrast, OCT4 is strongly upregulated in
the distal part towards the terminal vesicle, the tip of the spinal cord (Figure 22 D). Furthermore, OCT4
is not only restricted to the spinal cord but also expressed in the mesenchyme of the regenerate. Magnified
images of the spinal cord illustrated in a rainbow look-up table shows the high OCT4 expression in the distal
part of the spinal cord and the mesenchyme (Figure 22 D’).
Our results show that Sox2 mRNA and protein as well as Oct4 mRNA and OCT4 protein are localized in
non-amputated and 6-day regenerating spinal cord, with OCT4 being upregulated in the spinal cord and
mesenchyme of the regenerate.
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Figure 21: The transcription factors SOX2 and OCT4 are expressed in spinal cord of a non-
amputated tail
Axolotl juveniles of about 3 cm from snout to tip of the tail were used for immunohistochemical staining with
SOX2 or OCT4 antibody (white) (n=3 each). DNA was counterstained with Hoechst 33342 (blue). Scale
bars 100 µm. SOX2 is strongly expressed in the progenitor cells of spinal cord in a (A) proximal as well as
in (B) a distal tissue section of a non-amputated tail. Dashed circle shows the spinal cord. DRG... dorsal
root ganglion. (C) OCT4 is expressed at a low level in proximal region and (D) distal part of the spinal
cord. (C’) Higher magnification of OCT4 expression level in the spinal cord in a rainbow look-up table at a
proximal tissue section. (D’) Higher magnification of OCT4 expression level in the spinal cord in a rainbow
look-up table of a distal section. In the rainbow look-up table the expression level is illustrated as a gradient
from black to red, indicating a low to strong expression, respectively.
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Figure 22: The transcription factors SOX2 and OCT4 are expressed in spinal cord of a day-6
regenerating tail
Axolotl juveniles of about 3 cm from snout to tip of the tail were used for immunohistochemical staining
with SOX2 or OCT4 antibody (white) (n=3 each). Dashed line in the cartoon shows the amputation plane.
DNA was counterstained with Hoechst 33342 (blue). Scale bars 100 µm. SOX2 is strongly expressed in
the progenitor cells of the spinal cord in (A) a proximal as well as in (B) a distal tissue section of a day-6
regenerating tail. (C) OCT4 is expressed at low level in proximal spinal cord (D) but is upregulated in
the spinal cord and mesenchyme of distal regenerating tail. (C’) Higher magnification of OCT4 expression
level in the spinal cord in a rainbow look-up table at a proximal tissue section. (D’) Higher magnification of
OCT4 expression level in the spinal cord and mesenchyme in a rainbow look-up table of a distal regenerating
section. In the rainbow look-up table the expression level is illustrated as a gradient from black to red,
indicating a low to strong expression, respectively.
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7.2.4 Knockdown of OCT4 leads to a shorter regenerating spinal cord and to a decrease of
cycling cells
We showed that Sox2 and Oct4 mRNA and protein are expressed in non-amputated and 6-day regenerating
spinal cord, with OCT4 being upregulated in the regenerating spinal cord. This suggests that OCT4 is in-
volved in spinal cord regeneration. Hence, we were interested in the effect of downregulating OCT4. The only
possibility to knockdown expression of a protein in axolotl is by injecting morpholino, a short oligonucleotide
complementary to the mRNA and thus inhibiting protein expression. We decided for morpholinos blocking
translation of OCT4, SOX2 and POU2. We also used a standard control morpholino. When Oct4-, Sox2-
and Pou2-morpholino were used together, they were mixed in a volume ration of 1:1:1. All morpholinos are
fluorescein isothiocyanate (FITC)-labeled and thus detectable with fluorescence light.
We injected the spinal cord of 3 cm larvae (snout to tail tip) with 3 µl of 1 mM morpholino and electroporated
immediately (Figure 23 A). Four days later we amputated the tail where the amputation plane went through
the highest amount of morpholino positive cells visible in a dissecting microscope. A high efficiency of
morpholino positive cells was the main criteria for this experiment. To determine this we sectioned the
amputated tail close to the amputation plane, and assessed the amount of morpholino positive cells.
The distribution of morpholino into the cells was not equal and thus there were animals having zero or only a
few cells showing morpholino uptake (Figure 23 B). By contrast, other animals had weak positive and strong
morpholino positive progenitor cells in the spinal cord. An example using standard control morpholino or
Sox2-morpholino injected into spinal cord is shown in Figure 23 C and Figure 23 D, respectively. We only
performed further analyzes on animals showing more than 50% of morpholino positive progenitor cells in the
spinal cord.
Six days after amputation the length of the regenerated spinal cord was measured and result plotted in
Figure 23 E. We observed a significant reduction in spinal cord regeneration of OCT4 knocked down animals
compared to animals injected with standard control morpholino (p < 0.005). However, we did not detect
any difference when POU2 expression was knocked down. Spinal cord regeneration was reduced in SOX2
knocked down animals but to a lesser extent than in OCT4 knock downs. Regenerated spinal cord in animals
injected with Oct4-, Sox2- and Pou2-morpholino together was longer than with Oct4- or Sox2-morpholino
injected alone, but shorter than when POU2 is knocked down. This effect is probably due to the fact that
morpholinos were used in a volume ration of 1:1:1, which led to a lower amount of each morpholino in a cell.
Further, we determined whether morpholino weak and strong positive spinal cord cells were able to proliferate.
Therefore we performed tail sections of three regenerating animals and stained regenerate and mature spinal
cord, maximally 500 µm proximal to amputation plane, for Proliferating Cell Nuclear Antigen (PCNA) a
marker for proliferating regenerating cells. From the staining results we calculated the percentage of PCNA
expressing progenitor spinal cord cells which had a weak and strong standard control-, Sox2- and Oct4-
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Figure 23: OCT4 and SOX2 knockdown results in a shorter regenerating spinal cord
(A) Axolotl juveniles of about 3 cm were injected with morpholino (standard control n=8, Pou2 n=10, Sox2
n=10, Oct4 n=9, Pou2/Sox2/Oct4 (v/v 1:1:1) n=10) and electroporated four days before tail amputation.
Amputated tail close to the amputation plane was sectioned to determine the amount of morpholino positive
cells. On day-6 length of regenerated spinal cord was measured and tissue was used for staining. (B) Example
of low morpholino uptake. Only a few cells are Pou2-morpholino positive (green). Animals were not used
for further procedure. (C) Example of higher standard control and (D) Sox2-morpholino (green) uptake
in spinal cord close to amputation plane. Red arrowheads indicate weak, white strong morpholino positive
cells. Animals were used for further procedure. DNA was counterstained with Hoechst 33342. Scale bars 100
µm. Dashed circles mark spinal cord. (E) length of the regenerating spinal cord on day-6 after amputation.
Compared to standard control morpholino regenerating spinal cord length is significantly reduced in OCT4
knocked down animals (p < 0.005). POU2 knocked down does not have an effect on regenerated length
while SOX2 knock down phenotype is stronger than POU2. (F) Day-6 regenerate was stained for PCNA
and percentage of PCNA expressing progenitor spinal cord cells with a weak and strong standard control-,
Sox2- and Oct4-morpholino uptake was calculated. Remaining cells were PCNA negative.
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morpholino uptake.
We found that 82% to 100% of the standard control morpholino positive cells were PCNA positive (Figure
23 F). However, SOX2 knockdown led to a dramatic decrease of PCNA expression in spinal cord progenitors.
Only 45% of weak Sox2-morpholino positive cells expressed PCNA. PCNA is even more repressed in strong
Sox2-morpholino positive cells (4%). Compared to control we observed a drastic PCNA downregulation in
OCT4 knock down cells. Only max. 34% of cells injected with Oct4-morpholino expressed PCNA.
7.2.5 Lineage tracing of SOX2 expressing cells from regenerating spinal cord is not efficient
using Sox2 reporter transgenic strain
From our OCT4- and SOX2 knock down experiment we have learnt that spinal cord cells show reduced
proliferation, and the regenerated length is shorter. This would indicate that Oct4 and Sox2 play a role in
regenerating spinal cord. Further we showed that SOX2 in the spinal cord is only expressed in progenitor
cells while OCT4 expression is not restricted to just spinal cord. With lineage tracing experiments, where
SOX2 expressing cells are labeled, we wanted to follow OCT4 and SOX2 positive cells from regenerating
spinal cord.
Toward this aim, we used a technique based on the Cre/LoxP recombination, with which one can turn gene
expression on and off in a specific tissue or cell types (Sauer, 1998). We created a transgenic reporter system
that would allow us to identify, isolate and follow SOX2 expressing cells from the regenerating spinal cord.
Figure 24 A shows the strategy of this experiment. In our laboratory we have generated a number of lines of
germline transgenic animals harboring the LoxP reporter construct where the ubiquitous CAGGs promoter
expresses a floxed EGFP - 3-Poly-Adenylation site followed by the Cherry gene. In addition, we produced
several lines of animals where the axolotl Sox2 genomic sequence drives an inducible Cre-recombinase-ERT
which should specifically induce recombination of the LoxP construct in all SOX2 expressing cells, leading
to CHERRY expression in all SOX2 positive cells.
We injected 4-OH-Tamoxifen to induce CRE expression into the progeny. We observed conversion from EGFP
to a strong CHERRY expression in the brain of the animals. However, we did not see any conversion in the
spinal cord of the tail. To trigger SOX2 expression in the spinal cord and thus to increase the conversion
we amputated a part of the tail from the offspring and injected them with 4-OH-Tamoxifen. However, the
conversion efficiency in the tail was very low. By immunofluorescence staining we observed a few CHERRY
expressing cells in the mature spinal cord (Figure 24 B), but none in the regenerate.
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Figure 24: Transgenic reporter animals for lineage tracing of SOX2 expressing cells from spinal
cord
(A) Experimental approach. A mating of a CAGGs-LoxP-EGFP-LoxP-Cherry with a Sox2-ERT-CRE-
nucEGFP animal was set up (grey boxes show the promoter). The tail of the EGFP expressing offsprings
was amputated and 6 days later injected with tamoxifen to induce CRE expression under the control of the
Sox2 promoter. CRE recombinase excises LoxP-EGFP. All SOX2 expressing cells would express CHERRY
under the CAGGs promoter. (B) Immunohistochemical staining to determine conversion of LoxP reporter
in the mature part of an amputated, tamoxifen-injected tail. SOX2 (white) is expressed in the spinal cord,
CHERRY conversion is shown in red indicated by an arrowhead. EGFP (green) is ubiquitously expressed
including the spinal cord. DNA was counterstained with Hoechst 33342. The merge image shows the overlay
of all four channels. Dashed line indicates the spinal cord. Scale bar 100 µm.
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7.2.6 Transplanting neural ectoderm labels SOX2 spinal cord cells used for lineage tracing
Due to the low efficiency of conversion in the reporter line we performed embryonic transplantations to label
spinal cord cells. Therefore, we used neurula stage embryos and grafted a cell cluster of about 4 to 10 cells
from neural plate ectoderm of a CAGGs-EGFP donor onto a non-GFP host of the same stage (Figure 25 A).
Transplantation of only a small cell cluster compared to the entire section of the neural plate responsible for
spinal cord formation allows us to cleanly label only spinal cord cells. However, because of the low number
of these cells it is not possible to label the entire spinal cord.
All transplanted animals we screened for GFP expression in the spinal cord after hatching. Figure 25 B
shows an example of a transplanted animal expressing GFP in a spotted manner in the spinal cord. The
amount of GFP labeled spinal cord cells is limited when only a small cell cluster was transplanted. This can
be abolished when we amputate the tissue through the GFP expressing cells (see dashed line in Figure 25 B).
It led to an elongation of the GFP labeled spinal cord. On day-6 we observed GFP expression in regenerating
spinal cord (Figure 25 C). This method ensures that we minimize contamination and label only spinal cord
cells.
To determine GFP expression in the spinal cord we performed immunofluorescence staining on cross sections
and could identify a co-localization with the spinal cord progenitor marker SOX2 (Figure 25 D). Further
GFP was expressed in neurons of the spinal cord, the cell bodies and also in the outgrowing axons (Figure
26 A). Immunofluorescence staining with βIII TUBULIN (Figure 26 B), a microtubule protein exclusively
expressed in neurons, showed co-localization (Figure 26 D). Confocal images document this observation in
more detail. Co-localization of GFP (Figure 26 A’) and βIII TUBULIN (Figure 26 B’) is visible in Figure
26 D’.
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Figure 25: Embryonic transplantation to label spinal cord cells for lineage tracing studies of
SOX2 positive cells
(A) A mating of CAGGs-EGFP donor with non-GFP host animals was set up. Offsprings were used for
grafting experiments. A small ectodermal cell cluster from CAGGs-GFP donor of a neurula stage embryo
was transfered to the same position in a non-GFP recipient. After hatching animals were screened for GFP
expression in the spinal cord with a dissecting microscope. (B) Tail of a grafted animal in brightfield (BF)
and GFP channel. Scale bar 2 mm. GFP is expressed in a spotted pattern in the spinal cord. Amputation
(dashed line) through GFP expressing cells (C) elongated GFP labeled spinal cord. Regenerating tail six
days after amputation in darkfield (DF) and GFP channel. Scale bar 2 mm. (D) Immunohistochemical
staining of a cross section of the regenerating tail. Spinal cord is partially GFP labeled which co-localizes
with SOX2. DNA was counterstained with Hoechst 33342. Merged image shows the overlay of all three
channels. Dashed circle marks spinal cord. Scale bar 100 µm.
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Figure 26: GFP labeled animals due to ectodermal transplantation express GFP in cells of the
neural system
Immunohistochemical staining of a cross section from the mature part of the tail. DNA was counterstained
with Hoechst 33342 ((C), (C’)). Scale bar 100 µm. (A) Shows expression of GFP in spinal cord and cells
of the neural system. (B) Staining for βIII TUBULIN a neural cell marker. Dashed square is magnified and
shown by the confocal images. (A’) GFP expression co-localizes with βIII TUBULIN (B’). Merged images
show the overlay of all three channels ((D), (D’)).
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We wanted to confirm that due to the transplantation and amputation of the tail no muscle cells were labeled.
Hence we stained sections of the regenerating tail with the muscle marker myosin heavy chains (MHC) and
calculated the percentage of double positive GFP/MHC expressing cells, indicating muscle formation and
compared it to cells double positive for GFP/βIII TUBULIN indicating neurons. The result is shown in Table
2. Transplantation of GFP neural ectoderm cluster to one side of the neural plate ectoderm led to about
55% GFP expressing spinal cord cells per tissue section. We determined about 43% of GFP/βIII TUBULIN
expressing neurons outside the spinal cord. There were no cells expressing GFP/MHC. Figure 27 shows an
example of distinct cells expressing GFP and MHC. This shows that animals obtained by transplantation
show only GFP expression in spinal cord and neurons but not in muscle tissue, and thus can be used for
further cell tracking experiments.
Table 2: Embryonic transplantation labels spinal cord including neurons, but no muscle cells
% of GFP labeled spinal
cord cells
% of GFP/βIII TUBULIN
expressing cells
% of GFP/MHC expressing
cells
54.8% (+/- 9.1%) (ncells=851) 43.1% (+/- 11.3%) (ncells=551) 0% (ncells=209)
MHC DNAGFP merge
notochord
Figure 27: No co-localization of muscle cells and GFP-labeled cells from the spinal cord
Immunohistochemical staining of a cross section in the mature region. GFP is expressed in the spinal cord
and axons due to transplantation in neurula stage embryos. GFP does not show co-localization with myosin
heavy chains (MHC) indicated by arrowheads. DNA was counterstained with Hoechst 33342. Merged image
shows the overlay of all four channels. Dashed circle marks spinal cord. Scale bar 100 µm.
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7.2.7 In an embryonic context pluripotent spinal cord cells form muscle
With our final experiment we wanted to investigate whether regenerating spinal cord cells, expressing OCT4
and SOX2 have a pluripotent character. Hence we performed in vivo studies and transplanted regenerating
spinal cord cells into somites of an embryo. Spinal cord developed from the ectoderm during embryogenesis. In
contrast, somites are mesodermal cells and form skeletal muscle, dermis and the vertebrae. By transplanting
spinal cord cells into the niche of muscle forming tissue we have the ability to judge whether spinal cord cells
form another cell type and hence are pluripotent.
For the experiment we used spinal cord of a day-6 regenerating tail since OCT4 is upregulated compared
to non-amputated and very proximal mature tissue. The animal we used was obtained from embryonic
transplantation (see chapter 7.2.6). Evaluation of the transplanted animals showed that cells of the spinal
cord are GFP expressing, but muscle cells did not. Hence, we used this animal for lineage tracing of spinal
cord cells when transplanted into somites. We dissected mature spinal cord close to the amputation plane
and the regenerating spinal cord six days after amputation. To disrupt the cell-cell contact we incubated
the spinal cord in a papain ovomucoid mixture and transplanted the disrupted cells into somites of a somite
stage axolotl embryo (Figure 28 A). We performed 12 transplantation experiments.
Figure 28 B shows an example of GFP labeled spinal cord cells into somites of an axolotl. After hatching
we identified GFP expression in ten out of twelve transplanted animals using a dissecting microscope. We
sectioned the tissue of the ten animals and stained for GFP (Figure 28 C) and MHC (Figure 28 D). Inter-
estingly, in all cases we observed co-localization of GFP and MHC, shown in Figure 28 F. Confocal images
illustrate this observation in more detailed way (Figure 28 C’, D’, E’, F’).
This result suggests that regenerating axolotl spinal cord cells are pluripotent and can give rise to muscle
cells when brought into an embryonic context.
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Figure 28: In an embryonic context spinal cord cells can form muscle
(A) Experimental approach. Day-6 regenerating spinal cord was dissected from a host with GFP labeled
cord. Cell clump was treated in papain ovomucoid mix for a better cell disruption before transplanting GFP
expressing cells it into somites of an axolotl embryo. (B) Transplantation of GFP labeled spinal cord cells
into somites. Scale bar 1 mm. BF... brightfield. Hatched animals were checked for GFP expression using a
dissecting microscope. Positive animals (10/12) were sectioned and stained for GFP (C) and (D) MHC. (E)
DNA was counterstained with Hoechst 33342. (F) Overlay of the different channels, indicates co-localization
of GFP and MHC. Dashed circle illustrates the spinal cord. Magnification of the GFP and MHC expressing
cells (indicated with a dashed rectangle) is shown in the confocal images. (C’) GFP (green), (D’) MHC
(red), (E’) DNA (blue) and (F’) merge. Scale bar 100 µm.
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7.3 Discussion
In the present study we characterized of the transcription factors Oct4, Pou2 and Sox2 in spinal cord regen-
eration after axolotl tail amputation. Furthermore, we traced SOX2/OCT4 expressing spinal cord cells in
axolotl embryos after transplantation. We could show for the first time that spinal cord cells have an in vivo
potential to form muscle cells in an embryonic context.
7.3.1 Axolotl OCT4 and SOX2 play a key role in spinal cord regeneration
From mammalian systems as well as amphibians it is known that the transcription factor Oct4 is expressed
during cleavage stages in embryo development and is an essential key player for the differentiation process
of blastocysts (Nichols et al., 1998; Bachvarova et al., 2004). Later, OCT4 expression becomes restricted to
the inner cell mass and epiblast, and after gastrulation OCT4 is expressed in primordial germ cells (Nichols
et al., 1998; Morrison and Brickman, 2006; Downs, 2008). In mouse, Downs (2008) detected OCT4 in distinct
epiblast-derived embryonic and extraembryonic tissue up to a developmental stage of 16-somite pairs.
In our study on axolotl we found that Oct4 is not only restricted to germ cells but also present in somatic
cells. We identified an upregulation of Oct4 and Pou2 mRNA in spinal cord and mesenchymal cells of a day-6
regenerate compared to non-amputated tail. OCT4 protein showed an identical expression pattern. SOX2
expression was highly abundant but restricted to progenitor cells of the spinal cord without a significant
change between non-amputated tail and regenerate. In contrast, in xenopus tail amputation leads to a global
increase in SOX2, and a proliferation of SOX2 expressing cells (Gaete et al., 2012). By overexpressing a
dominant negative form of SOX2, Gaete et al. (2012) showed a decrease in proliferation of spinal cord cells
which affected tail regeneration. This suggests that xenopus SOX2 is necessary for the process of spinal
cord regeneration. We had a similar result in axolotl. To study the loss of a gene function in axolotl, the
use of a morpholino, blocking mRNA translation to protein is necessary. SOX2 was required for spinal cord
regeneration but to a lesser extent than OCT4, which decreased the regenerated length significantly compared
to control. Even though, with Sox2-morpholino we did not observe the phenotype of a significantly shorter
regenerated spinal cord, about 45% of SOX2 knocked down cells were no longer cycling and proliferating. This
would indicate that axolotl SOX2 has an effect in regeneration. One may be able to prove that by applying
a higher amount of Sox2-morpholino to spinal cord cells by either using higher morpholino concentration,
injecting and electroporating the tail over several days before amputation, or changing the electroporation
conditions to improve the number of Sox2-morpholino positive cells.
In zebrafish Pou2 and Sox2 were expressed before and during fin regeneration, suggesting that both are
required for the regeneration process. However, none of the factors was upregulated in regenerating fin tissue
compared to non-regenerating tissue (Christen et al., 2010). POU2 knockdown in one or two day blastema
cells reduced dorsal fin outgrowth by 40%, while SOX2 was also required for fin regeneration but to a lesser
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extent (Christen et al., 2010). The researchers claimed that Pou2 is a crucial gene in fin regeneration.
We could also show that Oct4- and Sox2-morpholino electroporated cells are less proliferating. PCNA
expression is diminished to at least 33% and 45% of the cells, respectively. Further, OCT4 knockdown
animals regenerated a shorter spinal cord. Taken together, this would indicate that Oct4 and to a lesser
degree also Sox2 are important in spinal cord regeneration of the axolotl.
7.3.2 Cell lineage tracing studies require an efficiently labeled cell type of interest
From previous studies it was known that cells keep the memory of their tissue origin during axolotl limb
regeneration (Kragl et al., 2009). However, it remained unclear whether progenitor cells from the spinal cord
are restricted in their lineage of neural cells or whether they have the ability to form other cell types in a
different environment. We therefore carried out lineage tracing experiments. One of the standard methods
to perform long-term cell fate tracing is to develop transgenic axolotls.
We used germline transgenic animals harboring the LoxP reporter construct with the ubiquitous CAGGs
promoter expressing a floxed EGFP - 3-Poly-Adenylation site followed by the Cherry gene. In addition, we
have other animals where the axolotl Sox2 genomic sequence drives an inducible Cre-ERT which would induce
recombination of the LoxP construct in all Sox2 positive cells. However, the efficiency of the conversion from
EGFP to CHERRY in the spinal cord by injecting 4-OH-Tamoxifen to the progeny was very low.
One reason for the low conversion might be that the Sox2 promoter fragment is a genomic sequence which
was isolated from the axolotl genomic phage library. Thus, it might not have all required elements and
enhancers necessary for an expression in spinal cord. But it might have the regulatory elements that give
strong expression in brain.
It is known that chick Sox2 has eight distinct enhancers (Uchikawa et al., 2003). The different enhancers
control different expression pattern in the chick embryo (Saigou et al., 2010; Uchikawa et al., 2003). The
enhancer element N4, downstream of Sox2 is active in mesencephalon, spinal cord, lateral head and ectoderm
in chick embryos before stage 20. In later stages spinal cord Sox2 is activated by the enhancer elements N1
and N4 as well as by a conserved block SC2. SOX2 expression in the brain however, is regulated by the
upstream enhancer elements N3 and N2, and the downstream ones N5 and N4 (Uchikawa et al., 2003). This
might be an explanation why we had such a weak conversion in the spinal cord of our transgenic animals. To
increase the conversion efficiency it would be necessary to create a construct containing a longer downstream
sequence of Sox2 including all enhancer elements necessary for SOX2 expression in the spinal cord.
7.3.3 Pluripotent spinal cord cells form muscle when brought in an embryonic context
Even though transgenic animals would be a much cleaner source for cell fate studies, the conversion efficiency
was at a very low rate and thus this strategy was not possible to use for lineage tracing experiments. Thus,
it was necessary to label cell types by transplantation. We transplanted ectodermal cells from neural plate
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constantly expressing GFP (Sobkow et al., 2006) into the same position of a non-GFP recipients and observed
GFP expression in the spinal cord and axons. Due to the fact that GFP cells were only transplanted to one
half of the neural plate only about 55% of spinal cord cells were GFP labeled. When the tail of the animal
is amputated, the GFP labeled spinal cord cells will only form spinal cord during the regeneration process in
agreement with Kragl et al. (2009). Hence our studies coincide with the result from axolotl limb regeneration
studies where cells keep their memory. This restriction however, depends on the environment of the spinal
cord cells. We showed for the first time that OCT4/SOX2 expressing spinal cord cells have the potential to
change their fate in an embryonic context when one changes the environment. We obtained muscle formation
when these spinal cord cells were transplanted into somites, the niche for muscle development. However, our
data do not indicate whether muscle is formed directly from the spinal cord or whether spinal cord cells fuse
to developmental myoblasts, a cell type of embryonic progenitors, which give rise to muscle cells.
Studies on mouse showed that progenitor cells of the CNS are able to generate non-neural derivatives (Ying
et al., 2002). The investigators used cells from mouse brain and co-cultured them with pluripotent ES cells,
showing that brain cells do not generate directly ES cells, but the conversion takes place through generation of
tetraploid hybrid cells by spontaneous fusion of ES cells and cells from the CNS (Ying et al., 2002). Further,
it has been reported that stem cells from the CNS can give rise to the haematopoietic cell lineage (Bjornson
et al., 1999), but more interestingly also to muscle when co-cultured with skeletal myoblasts (Galli et al.,
2000). It had been further discussed that stem cells of the nervous system change fate during co-culturing
with differentiating ES cells, when forming multinucleated myotubes (Clarke et al., 2000). Also other studies
show that in mouse stem cells derived from adult bone marrow are able to repair liver tissue via fusion to
the host liver cells (Wang et al., 2003; Vassilopoulos et al., 2003). These reports all indicate that cell fusion
is able to remove some of the barriers for one cell type to become another.
Our experimental approach lacks of the possibility to detect fusion of the spinal cord cells with muscle cells.
As markers we used the cytoplasmic GFP in the spinal cord, and the cytoplasmic myosin heavy chain marker
for muscle cells. Since none of the marker labels the nuclei we can not exclude cell fusion. Thus, it would
be better to use transgenic animals having spinal cord cell labeled nuclear GFP and transplant them into
somites. The staining should be performed using a muscle nuclei specific marker, like the nuclear transcription
factor myocyte-specific enhancer factor 2C, also called Mef2c. Since in this case the nuclei would be labeled,
one would be able to detect multinucleated cells, and thus obtain evidence about cell fusion.
To clearly define whether regenerating OCT4/SOX2 expressing spinal cord cells have a pluripotent character
it would be necessary to transplant cells into endoderm for example. Endodermal cells give rise to cells of
the gastrointestinal tract, respiratory tract, endocrine glands, to auditory and urinary system, but not to
muscle. Further it would be interesting to determine whether spinal cord cell of the very mature part would
have the same capacity as the spinal cord cells from the regenerating tail. Another experimental approach
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to determine the pluripotent character of OCT4 expressing spinal cord cells should be the transplantation of
OCT4 knocked down spinal cord cells. We can knock down OCT4 expression in spinal cord using morpholino.
We showed that these animals have a deficiency in spinal cord regeneration. Further, OCT4 knockdown cells
showed decreased cell proliferation, as indicated by lower number of PCNA expressing cells. This means that
cells are less proliferative, and maybe also less pluripotent if OCT4 were the main factor.
7.3.4 Summary II
Our results demonstrate, that Pou2, Oct4 and Sox2 are present in the spinal cord of non-regenerting and
regenerating spinal cord. Further, OCT4 was upregulated in regenerating spinal cord and mesenchymal cells.
Knockdown of OCT4 showed a significantly shorter regenerated spinal cord compared to control, whereas
SOX2 knockdown resulted in a slight decrease of the regenerated length only. This indicates that OCT4
plays a role in the process of epimorphic regeneration. To determine the pluripotent potential of regenerating
SOX2/OCT4 expressing spinal cord cells in vivo we transplanted cells into somites of embryos and observed
muscle formation. However, we cannot exclude fusion of spinal cord and muscle cells. This can be resolved
by labeling the nuclei of spinal cord and muscle. Thus, cell fusion with its multinucleated cells could be
detected. To clearly state whether regenerating OCT4 expressing spinal cord cells are pluripotent we have to
perform OCT4 knock down in spinal cord and transplant these less proliferating cells into embryos, observing
their cell fate.
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In this thesis we have studied the characteristics of the two pluripotency related genes Oct4 and the newly
identified Pou2, both belong to the group of PouV genes, as well as Sox2 from axolotl. All three genes are
present in the pluripotent animal cap cells during embryonic development and in spinal cord regeneration.
By in vitro we investigated whether axolotl POU2 and OCT4 expression have conferred a potent character to
cells like POU orthologs do in mammals. We could show that axolotl POU2 and OCT4 in combination with
the human or axolotl factors SOX2, c-MYC and/or KLF4 are able to reprogram mouse or human fibroblasts
and hence generate an iPS cell. Our results demonstrate that the axolotl factors can substitute human
orthologs as well as dimerize with the human proteins to initiate reprogramming. This would propose that
the ancestral class V POU already possessed a pluripotency conferring potential and this characteristic also
remained after the duplication of class V POU at the base of tetrapod development. Thus, the pluripotent
potential is a feature for Pou2 and Oct4. However, not all Pou orthologs from various species are able to
reprogram cells. Zebrafish POU2 did not show reprogramming ability. This means that at some point in
evolutionary history the pluripotency conferring potential of Pou2 in zebrafish disappeared (Morrison and
Brickman, 2006; Niwa et al., 2008).
By in vivo studies we characterized the transcription factors OCT4, POU2 and SOX2 in spinal cord regen-
eration after axolotl tail amputation. All three factors are present in regenerate. Knockdown of OCT4 and
SOX2 result in a shorter regenerated spinal cord. Further, the morpholino containing cells proliferate less.
This indicates that OCT4 and SOX2 play a key role during the regeneration process. Lineage tracing studies
showed that after amputation of the tail the cells from the spinal cord only form spinal cord again. This
observation is supported by studies on limb regeneration in axolotl. The lineage tracing experiments showed
that cell keep their memory of origin and hence the regeneration potential of the cells is restricted (Kragl
et al., 2009).
The restricted potential of the spinal cord cells expressing OCT4 and SOX2 however, depends on the environ-
ment of the spinal cord cells. We showed that OCT4/SOX2 expressing spinal cord cells have the potential to
change their fate when brought into an embryonic context. We obtained muscle formation when these spinal
cord cells were transplanted into somites, the niche for muscle development. Our observation is supported by
results from embryonic development. There it was reported that the chordoneural hinge, a tissue posterior to
the developing notochord during tailbud extension, represents at least one stem cell population which gives
rise to myotomes and cells of the CNS (Mathis and Nicolas, 2000; Nicolas et al., 1996; Gont et al., 1993;
Cambray and Wilson, 2002, 2007; McGrew et al., 2008) (also reviewed in Handrigan (2003)).
However, with our experimental approach we could not observe whether muscle cells are formed directly from
the spinal cord or whether spinal cord cells fuse to developmental myoblasts, which give rise to muscle. Our
data indicate that somatic cells from the axolotl tail spinal cord have the ability to dedifferentiate in vivo to
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become a more pluripotent cell. These cells are then able to re-differentiate and can form another cell type.
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9.1 Axolotl care
9.1.1 Breeding
Ambystoma mexicanum (axolotl) used for our experiments were bred in the facilities of the MPI-CBG,
BioTec and the CRTD where they were kept in aquariums (Aquarienbau Schwarz) filled with 18 ◦C tap
water. Juvenile animals (2-5 cm) were fed daily with freshly prepared Artemia salina (Fimo¨ Aquaristik
GmbH), and larger animals (above 5 cm) were fed 2-3 times per week with fish pellets (AXOBALANCE,
Aquaterratec).
9.1.2 Anesthetization of animals
For surgery and live microscopy, animals were anesthetized in tap water containing 0.01% ethyl-p-benzoate
(Sigma).
9.1.3 Dejelling of embryos
The embryos were transfered to a sieve, washed with tap water followed by 70% ethanol before rinsing it
with sterile water. The embryos were then collected in a petridish filled with 1x Steinberg’s (3.4 g/l NaCl,
0.05 g/l KCl, 0.205 g/l MgSO4 x 7 H2O, 0.56 g/l Tris, 0.08 g/l Ca(NO3)2 x 4 H2O; pH 7.4) including 1x
Anti-Anti (Gibco), an antibiotic-antimycotic mixture and 1.5 ml/l of the antibiotic Ciprobay 200 (Bayer).
Embryos were staged according to Bordzilovskaya (1989) and dejellied using two sharp forceps at least 24 h
prior to use in further experiments.
9.2 Axolotl manipulation
9.2.1 Injection of tamoxifen
Powdered 4-Hydrotamoxifin (Sigma) was dissolved in DMSO (Sigma) (10 mg/ml), aliquoted and stored in
liquid nitrogen. For each set of injections a fresh aliquot mixed with Fast green (Sigma) dye was used.
The anesthetized animal was weighted and 50 µg 4-Hydrotamoxifin per 1 g of body weight was injected
intraperitoneally using a syringe (Hamilton Messtechnik GmbH). The animal was kept in a hydration chamber
for 20 min before returning it to water.
9.2.2 Microinjection and electroporation of morpholino into axolotl spinal cord
Borosilicate glass capillaries (1.2 mm O.D. x 0.94 mm I.D., Harvard Apparatus) were clamped into the
Flaming/Brown Micropipette Puller (Model P97, Sutter Instrument CO.) and pulled (heat: 485, pull: 80,
velocity: 120, time: 80).
FITC-labeled morpholinos (GeneTools) (Table 3) were dissolved in distilled water to a final molar concen-
tration of 1 mM, mixed with Fast green (Sigma) in a ratio of 25:1 and transfered into the glass capillary.
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Table 3: Morpholinos
Morpholino name Sequence 5’ - 3’
Axolotl Oct4 TCTCCTGTCCCAAATGCCCAGCCAT
Axolotl Pou2 CACGGTATCTCTTCCGAGCATCGGC
Axolotl Sox2 CGGTCTCCATCATGCTGTACATGGC
Standard control CCTCTTACCTCAGTTACAATTTATA
The capillary was fixed in the injection stage connected to the PV830 Pneumatic PicoPump (WPI). The
anesthetized animal (3 cm snout to tip of the tail) was placed on the injection stage under a dissecting
microscope, and morpholino was injected into the spinal cord.
Injected animal was immediately transfered to a 2% agarose dish filled with ice cold 1x phosphate-buffered
saline (PBS) which was cut out to hold the animal in place for the electroporation. Electroporation was
fulfilled using stainless steel tweezer electrodes (BTX Harvard Apparatus). Pulses (50 V, 50 ms, 5 pulses, 1
s interval, bidirectional, 7 mm distance of electrodes) were generated by Electro Square PoratorTM ECM830
(BTX Harvard Apparatus).
9.2.3 Transplantations
Cells of the spinal cord were labeled by transplantations. Matings using non-GFP and a GFP animal were
set up, whereas non-GFP neurula stage embryos were used as hosts. The transgenic donor expressed GFP
under the control of the ubiquitous CAGGS promotor (Sobkow et al., 2006) and was at the same stage as
the recipient embryo. A scheme is shown in Figure 29.
CAGGs-GFP 
donor
non-GFP 
recipient
Figure 29: Scheme of ectodermal transplantion
Ectoderm of CAGGs-GFP donor from neural plate is transplanted into non-GFP host. A cell cluster of about
4-10 cells was grafted into a non-GFP recipient to label spinal cord cells.
Petri dishes with a diameter of 3 cm filled with 2% agarose prepared in 1x Steinberg’s (for recipe see chapter
9.1.3) were flamed and filled with 1x Steinberg’s including 1x Anti-Anti (Gibco) and 1.5 ml/l Ciprobay 200
(Bayer). All following procedures were carried out using sterile conditions.
Dejellied wild type embryo was transfered to the petri dish, and transparent membrane around the embryo
was removed using forceps. The embryo was fixed by placing in a mold cut into the agarose. A small area
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of the ectoderm from the neural plate was removed and a cluster of about 4-10 GFP labeled ectodermal
cells was transfered by mouth pipetting. GFP labeled ectoderm cells were isolated as follows: To avoid cell
attachment a drop of 1% bovine serum albumin (BSA) was placed on the bottom of three different petri
dishes. Two of the dishes were filled with CMF-NT, and one with NT-solution (Niu, 1953) (for recepies see
Table 4 and 5). The donor was transfered to the dish filled with CMF-NT, and cells from the ectoderm of
the neural plate were scraped off with a tungsten needle and a forceps. Any mesodermal cells attached to
the ectoderm were removed. Ectodermal cells were transfered by mouth pipetting using a BSA coated glass
capillary to the second dish filled with CMF-NT. Cells were dissociated so that only clusters of about 4-10
cells remained. Immediately cells were transfered to NT-solution and used for transplantation into the donor.
Between two to four days after transplantation, embryos were transfered to a fresh agarose dish filled with
1x Steinberg’s including 1x Anti-Anti and 1.5 ml/l Ciprobay 200.
All six solutions for preparing CMF-NT and NT-solution (Table 4 and 5) were autoclaved separately. After
cooling component A, B and C of CMF-NT solution as well as NT solution were mixed in a ratio of 2:1:1. To
both solution 1.5 ml/l Ciprobay 200 (Bayer) and the antibiotic-antimycotic mixture Anti-Anti (stock 100x,
Gibco) to 1x final was added.
Table 4: CMF-NT solution used in transplantation
Component A Amount
NaCl 3.40 g
KCl 0.05 g
Ca(NO3)2 x 4 H2O 0.08 g
Mg(SO4) x 7 H2O 0.10 g
Distilled water 500 ml
Component B Amount
Na2HPO4 0.11 g
KH2PO4 0.02 g
Distilled water 250 ml
Component C Amount
NaHCO3 0.20 g
Distilled water 250 ml
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Table 5: NT solution used in transplantation
Component A Amount
NaCl 2.943 g
KCl 0.05 g
Distilled water 500 ml
Component B Amount
Na2HPO4 1.30 g
KH2PO4 0.115 g
Distilled water 250 ml
Component C Amount
NaHCO3 0.20 g
Distilled water 250 ml
9.3 Microscopy
9.3.1 Dissecting microscopy
Embryos or anesthetized animals were transfered to a petridish and imaged using the Olympus SZX16 with
the SDF PLAPO 1xPF objective (Olympus). Images were taken using the F-View camera (Olympus) and
CellF Soft imaging software.
9.3.2 Microscopy of tissue sections
To visualize fluorescence or bright field, digital images of axolotl tissue sections were taken on the Zeiss
Observer Z1 microscope. Images were taken using a 10x Plan-Neofluar (Numerical aperture (NA) 0.3 Ph1,
Zeiss) or a 20x Plan-Apochromat objective (NA 0.8, Zeiss) with an AxioCam MRm camera (Zeiss) for
black/white images or AxioCam MRc (Zeiss) for color images under the control of the AxioVision software.
Mosaic images were assembled using AxioVision program.
Confocal images were taken on Leica CRT 4000 using the 40.0x ACS APO (NA 1.15, Leica) oil objective.
9.3.3 Image processing
Measurements of fluorescence intensities were analyzed using the Fiji program.
9.4 Molecular Biology
9.4.1 Agarose gel electrophoresis
Agarose gels were prepared from agarose (Serva) disolved in 1x TBE (0.9 M Tris (Serva), 0.9 M Boric
acid (VWR), 10 mM EDTA (Merck)) by boiling. After allowing the solution to cool down, it was poured
into the chamber and Ethidium bromide (3,8-Diamino-5-ethyl-6-phenylphenanthridiniumbromid (Roth)) was
added directly to the agarose solution. DNA samples were mixed with 6x loading dye (30% (v/v) glycerol
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(VWR), 0.25% (w/v) bromophenol blue (Sigma Aldrich), 0.25% (w/v) xylene cyanol FF(Sigma Aldrich))
and electrophorezed in 1x TBE at 120 V for 20 to 60 min. When purified DNA was required, DNA was
extracted using the agarose gel extraction kit (Qiagen) following the manufacturers instructions.
RNA samples were electrophorezed for 15 min at 130 V to avoid degradation of the samples.
9.4.2 Polymerase chain reaction
PCR were carried out in a total volume of 20 µl. The reaction contained 0.5 µl 40 mM dNTPs (10 mM each,
Bioline), 2 µl 10x reaction buffer (MPI-CBG), 0.2 µl of forward and reverse primer (stock 100 mol/l) (Sigma)
and 5 units of Taq or Taq-Pfu polymerase mix (MPI-CBG). For amplification of axolotl Oct4 from gastrula
stage cDNA, 1x CES (for 5x CES use 2.7 M betaine, 6.7 mM DTT, 6.7% DMSO, 55 µg/ml BSA) (Ralser
et al., 2006) was added to the reaction mix. Either 5 µl of cDNA or 50 ng of plasmid DNA was used as a
template. Depending on the annealing temperature of the primers and the length of the generated product,
30 cycles with 30 s at 95 ◦C, 30 s at 55-70 ◦C and 30-90 s at 72 ◦C were performed. Primers used for PCR
to amplify Sox2 are shown in Table 6. All other primers are summarized in Table 7. The PCR amplified
products were electrophorezed in an agarose gel or purified using PCR purification kit (Qiagen) according to
the protocol the company provided.
Table 6: Primers used for PCR to amplify Sox2
Primer name Sequence 5’ - 3’
Sox2-5UTR-RT-F AAATAATAACCCGAAATCAGTGAAGAA
Sox2-5UTR-RT-R TGTAAAGTCACTTCAGTCTTTTGGAG
9.4.3 RNA extraction
The extraction of total RNA from axolotl tissue was performed according to Mini RNeasy kit (Qiagen) using
the protocol ”Purification of total RNA from animal tissue”. Briefly, frozen tissue was transfered to a 5 ml
tube and Buffer RLT was added. Tissue was disrupted and homogenized using a blender. Total RNA was
eluted in 30 µl of RNase free water and RNA concentration determined on the NanoDrop (Thermo Scientific).
RNA was kept in liquid nitrogen.
9.4.4 cDNA preparation from total RNA
Total RNA samples of 500 ng to 1 µg were DNase treated by adding 1 µl 10x DNase I reaction buffer, 1 µl
DNase I (1 U/µl, Invitrogen) and made up to 10 µl with RNase free water. Reactions were incubated for 15
min at 25 ◦C. The enzyme was heat inactivated for 10 min at 65 ◦C and sample chilled on ice. Each sample
was divided into two. To one part RT III superscript enzyme will be added to generate cDNA. To the other
half RT III will be omitted and thus will be a negative control. Oligo d(T)-12-18 primer (1 µl, Invitrogen), 1
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µl of 40 mM dNTP mix (Bioline), 4 µl 5x first strand buffer (Invitrogen), 2 µl 50 mM MgCl2 (Invitrogen), 2
µl 0.1 M DTT (Invitrogen) and 1 µl RNase OUT (40 U/µl, (Invitrogen)) were added and made up to 19 µl
with RNase free water. The reaction was heated for 2 min at 42 ◦C and 1 µl of SuperScript III (Invitrogen)
was added to one set of the samples. The sample was mixed and reverse transcription was performed for 1
h at 42 ◦C. The enzyme was heat inactivated at 70 ◦C for 15 min, and the samples then cooled down on ice
and stored at −20 ◦C.
9.4.5 Preparation of in situ hybridization probe
Sense and antisense probes were prepared from DNA templates either by PCR or the plasmid was linearized
using one restriction enzyme. Template was purified using PCR purification kit (Qiagen) according to
provider’s protocol. Concentration of the purified DNA was measured on a photometer (NanoDrop) and 1
µg of DNA was used for in vitro transcription. DNA was mixed with 2 µl 10x transcription buffer (Roche),
2 µl DIG RNA labeling kit (Roche), 1 µl 0.1 M DTT (Invitrogen), 1 µl RNase OUT inhibitor (Invitrogen)
and 2 µl of an RNA polymerase (Sp6, T7) (MPI-CBG), and incubated for 2-3 h at 37 ◦C. RNA cleanup was
performed using RNeasyMini kit (Quiagen) following the manual provided. Probe was eluted using two 30 µl
distilled water additions and used at a dilution between 1:800 to 1:1200 in hybridization buffer. Probes were
stored at −20 ◦C and a samples was electrophorezed in an agarose gel before using to determine whether the
probe is still intact.
9.4.6 Identification of axolotl Pou2
An assembly of axolotl sequences derived from Sanger sequences (Habermann et al., 2004; Putta et al., 2004),
454 published sequences (Monaghan et al., 2009) and 454 unpublished sequences was performed using MIRA
3.0.
To identify a close paralog of the axolotl Oct4 sequence the contig assembly was checked using BLAST. This
resulted in the detection of axolotl Pou2 sequence fragment. When this fragment was BLAST searched to
NCBI RefSeq set, Pou2 sequences from different organisms were referred as the closest ortholog.
9.4.7 Axolotl Oct4, Pou2, Sox2, xenopus Pou91, medaka Pou2 and zebrafish Pou2 amplification
and cloning into retroviral vector
The different Pou orthologs were cloned into the pMX retroviral vector (Cell biolabs) by standard methods
using restriction enzymes and its buffers from the NEB company. For primer sequences see Table 7.
Axolotl Pou2 was isolated by PCR from our long-insert cDNA library using primers designed from the
identified contig sequence. Two PCR reactions were performed using Axolotl-Pou2 Fw1 and the vector
primer M13 Rv, and Axolotl-Pou2 Rv1 with M13Fw. The amplified products were sequenced, and the coding
sequence was amplified by PCR (Axolotl-Pou2fl-BamHI-Fw, Axolotl-Pou2-NotI-Rv) and directionally cloned
into the pMXs vector using BamHI and NotI restriction sites.
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Table 7: Primers used for cloning reactions
Primer name Sequence 5’ - 3’
Axolotl-Pou2 Fw1 AACGAGGCCGAGAACACAGACAACATG
Axolotl-Pou2 Rv1 AGGCTGAGGTCCTCTGCGATCTGAGA
M13 Rv GGAAACAGCTATGACCATG
M13 Fw TGTAAAACGACGGCCAGT
Axolotl-Pou2fl-BamHI-Fw ACTGGATCCATGCTCGGAAGA
Axolotl-Pou2-NotI-Rv AGAGCGGCCGCTTAGCTAATGCTG
Zebrafish-EcoRI-Fw ATCGAATTCATGACGGAGAGAGC
Zebrafish-T-A-Rv CCAAGCTGGTCCTTCGTTTTC
Zebrafish-T-A-Fw GAAAACGAAGGACCAGCTTGG
Zebrafish-XhoI-Rv TCGCTCGAGTTAGCTGGTGAGATG
Zebrafish-EcoRI-Fw ATCGAATTCATGACGGAGAGAGC
Zebrafish-XhoI-Rv TCGCTCGAGTTAGCTGGTGAGATG
Xenopus-BamHI-Pou91-Fw ATCGGATCCATGTATAACCAACAG
Xenopus-XhoI-Pou91-Rv TCGCTCGAGCTAGTTGCCTTGG
Medaka-Pou2-HindIII-Fw GCACAAGCTTATGTCTGACAGG
Medaka-Pou2-NCBI-Rv CTGTTGAAAGGTTCTCCTCCTCAGAGTCGC
Medaka-Pou2-NCBI-Fw GCGACTCTGAGGAGGAGAACCTTTCAACAG
Medaka-Pou2-XhoI-Rv TCGCTCGAGTCATCCTGTCAGGT
Oct4-RT-Fw3 GAGGCTGCAGCTGGAATTAG
Oct4-RT-Rv2 TATTCCAGGTATGGTGCAATAAAGT
Sox2-D-Fw1 ATGAAYGCITTYATGGTITGG
Sox2-D-Rv1 CRRTGCATIGGYTGCATYTG
Sox2-sRv1 AGCTGTCCATCCGCTGGCTGGAGTTCAT
Sox2-sFw2 GGCTACGGCATGATGCAGGAGCAGCT
Sox2-full-Fw TTTCAAAAAAGTCTCCCGGAGTTGTCAAAA
Sox2-full-Rv CGCTTAATCTCCTCTGTACAAAAATAGTCC
The vector pME18S-FL3 containing zebrafish Pou2 was obtained from imaGenes. However, this clones had a
point mutation compared to the sequence in the NCBI database. To eliminate this point mutation, Pou2 was
amplified as two fragments (Zebrafish-EcoRI-Fw and Zebrafish-T-A-Rv, Zebrafish-T-A-Fw and Zebrafish-
XhoI-Rv). PCR fragments were purified (Qiagen) and used as template for a further PCR reaction with
Zebrafish-EcoRI-Fw and Zebrafish-XhoI-Rv primer. The PCR product was purified, and Pou2 excised using
EcoRI and XhoI, and ligated into the same sites within the vector pMXs.
The xenopus Pou91 gene in the vector pCS2 was a kind gift from the Kno¨chel lab (University of Ulm). The
Pou91 sequence was amplified (Xenopus-BamHI-Pou91-Fw, Xenopus-XhoI-Pou91-Rv), the PCR product was
purified, Pou91 excised using BamHI and XhoI, and ligated into the same sites within pMXs vector.
The medaka Pou2 gene was amplified as two fragments (Medaka-Pou2-HindIII-Fw and Medaka-Pou2-NCBI-
Rv, Medaka-Pou2-NCBI-Fw and Medaka-Pou2-XhoI-Rv). PCR fragments were purified from an agarose gel
and used as template for the final PCR reaction with Medaka-Pou2-HindIII-Fw and Medaka-Pou2-XhoI-Rv
primer set. The product was purified from an agarose gel. Medaka Pou2 was digested with HindIII and
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XhoI, and ligated into the same sites within pMXs viral vector.
Axolotl Oct4 cDNA was PCR amplified from gastrula stage (stage 11) embryonic cDNA using Oct4-RT-Fw3
and Oct4-RT-Rv2 primers designed from a published sequence (Johnson et al., 2003b). Axolotl Oct4 was
digested using BstXI and cloned into pMXs vector.
Axolotl Sox2 cDNA fragment was PCR amplified from a day-6 tail blastema cDNA using Sox2-D-Fw1 and
Sox2-D-Rv1 primer. 5’RACE and 3’RACE were performed with Gene Racer Kit (Invitrogen) using primers
Sox2-sRv1 and Sox2-sFw2, respectively. The full-length axolotl Sox2 sequence was amplified from the day-6
tail blastema cDNA using Sox2-full-Fw and Sox2-full-Rv primer. Finally, axolotl Sox2 was cloned into pMXs
vector using BamHI and XhoI restriction enzymes.
9.5 Phylogenetic and synteny analysis
9.5.1 Phylogenetic analysis of POU orthologs and axolotl Oct4 and Pou2 synteny analysis
The analysis was carried out by R. Voss. In brief, phylogentic results were achieved with MRBAYES 3.2
using Bayesian Inference to develop consensus phylogenetic trees with the posterior probabilities estimated
by Markov chain Monte Carlo methods (Ronquist et al., 2011).
First, an alignment of the entire sequences of Oct1, Oct4, Oct6 and Pou2 genes across different species and
the zebrafish Brn3c gene as an outgroup was created. Gblocks was used to determine the most suitable
conserved region for the analysis. This was the DNA binding domain. Analysis using both the alignment
of the entire sequence and that of the DNA binding domain was carried out and we did not observe major
differences between the two consensus trees.
The criterion for the outgroup was a single sequence from a different class of POU factors. Jones model
(Jones et al., 1992) for amino acid substitutions was applied with the rate heterogeneity modeled by a
gamma distribution. Each consensus tree was calculated from two independent runs (four chains per run
with one cold and three heated chains), of 500000 tree generations each (samples taken every 1000), after
excluding 25% of samples. The convergence was measured by the standard deviation of split frequencies,
and the value for the presented tree was between 0.000 and 0.0677. Sequences used for alignment and tree
building are indicated in Table 8.
Genetic linkage mapping was performed according to a previous method (Voss et al., 2011). Primers were
designed to amplify DNA fragments from axolotl Pou2 and Oct4 that contained diagnostic single nucleotide
polymorphisms that were informative for mapping using a primer extension genotyping method (Smith et al.,
2005). Markers were mapped using MultiPoint 2.2 (Korol, 2003) and the Kosambi (Kosambi, 1944) mapping
function.
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Table 8: Sequences used for alignment and tree building
Species Accession Number Species Accession Number
Brn3c Zebrafish Q90435 / NP 571353.1 Oct1 Human P14859-1 / NP 002688.3
Oct1 Swine F1S265 / NP 999429.1 Oct1 Mouse P25425-1 / NP 035267.2
Oct1 Chick P15143 / NP 990803.1 Oct1 Opossum F7GF90 / -
Oct1 X. Laevis P16143-1 / NP 001095255.1 Oct1(A) Zebrafish O42276 / NP 571513.1
Oct1(B) Zebrafish A4IFW4 / NP 001082798.1 Oct6 Human Q03052 / NP 002690.3
Oct6 Rat P20267 / NP 620193.1 Oct6 Mouse P21952 / NP 035271.1
Oct6 Chicken O73861 / AAC18592.1 Oct6(A) X. Laevis P31363 / NP 001158054.1
Oct6(B) X. Laevis Q561L5 / NP 001096655.1 Oct6 Zebrafish Q90482 / NP 571236.1
Oct4 Human Q01860-1 / NP 002692.2 Oct4 Chimpanzee Q7YR49 / NP 001238970.1
Oct4 Macaque Q5TM49 / NP 001108427.1 Oct4 Cat D3U664 / NP 001166912.1
Oct4 Dog E2QTW5 / XP 538830.1 Oct4 Elephant G3T5K8 / XP 003422494.1
Oct4 Rabbit A2ICN2 / NP 001093427.1 Oct4 Swine Q9TSV5 / NP 001106531.1
Oct4 Bovine O97552 / NP 777005.1 Oct4 Rat Q6MG27 / NP 001009178.1
Oct4 Vole A0MPW0 / ABK34451.1 Oct4 Mouse P20263 / NP 038661.2
Oct4 Tammar D2EA24 / ACZ54717.1 Oct4 Platypus A7X5W5 / NP 001229656.1
Oct4 Lizard - / XP 003228387.1 Oct4 Axolotl Q5J1Q2 / AAT09163.1
Oct4 Bullfrog C1C4W5 / ACO52025.1 Oct25 X. Laevis Q7T103 / NP 001079832.1
Oct25 X. Tropicalis B3DM25 / NP 001123406.1 Oct60 X. Laevis Q91989 / NP 001081583.1
Oct60 X. Tropicalis B3DM23 / NP 001123836.1 Oct91 X. Laevis B7ZQA9 / NP 001081342.1
Oct91 X. Tropicalis F6TLT1 / XP 002942017.1 Pou2 Tammar D2EA25 / ACZ54718.1
Pou2 Opossum - / XP 003339690.1 Pou2 Stickleback G3PZT5 / -
Pou2 Platypus - / XP 001520175.1 Pou2 Chicken A7Y7W2 / NP 001103648.1
Pou2 Medaka Q6DVF4 / NP 001098339.1 Pou2 Carp D3YBA7 / ADC96616.1
Pou2 Cod Q2I0F8 / ABC84854.1 Pou2 Zebrafish Q90270-1 / NP 571187.1
Pou Hydra Reference Millane et al., 2011
9.6 Biochemistry
9.6.1 Protein expression for antibody production
Antibody against axolotl OCT4 was generated against amino acid sequence 1-161 of axolotl OCT4 protein.
The axolotl SOX2 antibody was raised against the amino acid sequence 1-44 of the SOX2 protein. Sequences
used for generation of the antibodies are shown in Table 9. Two fusion constructs, one to maltose binding
protein (MBP) another one to glutathione S-transferase (GST), were generated for each axolotl protein. The
protein was expressed in BL21(DE3) E.coli cells, induced with isopropyl-β-D-thiogalactopyranosid (IPTG)
and purified (MPI-CBG, Protein Expression and Purification facility).
GST-fusion constructs were used to inject the rabbit for polyclonal antibody production. The animal was
immunized followed by three boosts after several days (200 µg protein each time). The MBP-fusion construct
was used for affinity chromatography to purify the antibody from the serum (section 9.6.2).
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Table 9: Protein sequences of OCT4 and SOX2 used for antibody production
Protein Protein sequence
OCT4 M A G H L G Q E I G R A A Y G F G A Q A L H L G A G G L E A G G P G F L S E S Y
G P Y A G F K A L E Y A H G G A E G E G R P G A H G L A R A W Y P F S E A W G
P V Y G Q S G A G A G F E S S R V E V K V E R P D K E A G Y G Q Q H Q Q A W A
G Y F V P Q L A V P A R S P A S V A S G G Q V P A A P A S P S D D S P H S S T A
S S S S
SOX2 M Y S M M E T D L K P P A P Q Q T S T N P G S N N N S S N A K N S P D R V K R
P M N A F
9.6.2 Antibody purification
MBP-Sox2 and MBP-Oct4 were stored in 1x PBS (MBP-Sox2, MBP-Oct4). The buffer was exchanged using
a PD10 desalting column (GE Healthcare) equilibrated with 100 mM HEPES pH 8.0, 500 mM NaCl, 10 mM
Maltose. Afterwards CaCl2 was added to a final molarity of 80 mM to the protein.
Polyclonal SOX2 and OCT4 antibodies (MPI-CBG) produced in rabbit were purified in an affinity chro-
matography procedure using 1 ml NHS HiTrap columns (GE Healthcare) and a peristaltic pump (Gilson)
with a flow rate of 1.5 ml/min. The column was washed with 3 column volumes (CV, 1 CV = 1 ml) of
ice cold and freshly prepared 1 mM HCl. A protein concentration of 0.5 mg/ml MBP-Sox2 or MBP-Oct4
was used for an antigen recirculation (30 min, room temperature (RT)) to bind the MBP-fusion protein to
the resin. Unreacted NHS groups were blocked by adding 6 CV blocking buffer (0.5 M ethanolamine, 0.5 M
NaCl). The circulation was stopped and the column incubated for 30 min at RT. The column was washed
using 8 CV for each of the following solutions: 10 mM Tris pH 8.0, 100 mM glycine pH 2.6, 10 mM Tris pH
8.0, 100 mM triethylamine pH 11.5. This washing step was repeated before adding 22 CV 1x PBS.
Serum was thawed and diluted with an equal volume of sterile 2x PBS. NaN3 was added to a final concentra-
tion of 0.1%. Filtered serum (0.22 µm Millex GP, Millipore) was recirculating over the column overnight at
room temperature. Unbound proteins were removed by washing with 90 CV of wash buffer (1x PBS, 0.5 M
NaCl, 0.1% Triton R© X-100 (Serva)) followed by 30 CV 1x PBS and 12 CV 10 mM Tris pH 8.0. The antibody
was eluted with 0.1 M glycine pH 2.6 and collected in twenty 900 µl fractions. The pH value of the fractions
was neutralize immediately using 100 µl of 2 M Tris HCl pH 7.0. The column was then washed with 12 CV 10
mM Tris pH 8.0 and an elution using 0.1 M triethylamine pH 11.5 was performed. The elution was collected
as twenty 900 µl fractions. The pH value of the fractions was neutralize immediately using 100 µl of 2 M Tris
HCl pH 7.0. The IgG concentration of the separate fractions were measured, and protein containing samples
pooled and dialyzed in Slide-A-Lyzer Dialysis Cassettes 10K (10000 MWCO, Pierce) against 1x PBS at 4 ◦C.
Antibody aliquots were stored at −20 ◦C and −80 ◦C.
The column was finally washed with 18 CV 10x PBS, 18 CV storage buffer (55% glycerol (v:v) in 1x PBS)
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and stored at 4 ◦C.
9.7 Histology
9.7.1 Fixation and embedding of tissue
For in situ hybridizations axolotl embryos were staged, dejellied, and fixed overnight in MEM-FA (100 mM
MOPS, pH 7.4, 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde) at 4 ◦C.
Tail tissue was fixed for 3 days at 4 ◦C in MEM-FA prepared with 3.7% formaldehyde, washed in 1x PBS,
dehydrated in an ethanol (VWR) series, incubated in xylol (Roth), and embedded in paraffin (Roth). Tail
tissue and embryos were sectioned with a thickness of 10 µm on a rotation microtome (Leica RM2125RT).
For immunohistochemistry procedures tissue was fixed at RT for 4 h or at 4 ◦C overnight, dependent on
the size of the sample, in MEM-FA prepared with 1% formaldehyde, washed in 1x PBS and transfered to
embedding solution (20% sucrose in 1x PBS). Samples were incubated at 4 ◦C overnight while shaking, and
embedded in Tissue Tek (O.C.T. compound; Sakura) using molding containers (Polysciences). Tissue was
sectioned using a cryostat (Microm HM 560). The thickness of the section was max. 10 µm.
Newts A1 myoblasts were fixed for 15 min at RT in MEM-FA prepared with 1% formaldehyde before washing
with 1x PBS. Cells were directly used for immunohistochemistry.
9.7.2 In situ hybridization on sections
Cross-sections 10 µm thick were washed in xylol, rehydrated in an ethanol series, washed three times for
10 min in 1x PBS/0.1% Tween 20 (Sigma) and transferred to hybridization buffer (Table 10) containing
digoxigenin (Roche) labeled probe (see chapter 9.4.5) and hybridized overnight at 70 ◦C.
Table 10: Recipe for hybridization puffer
Component Amount
Dextran (Sigma) 5 g
DEPC treated distilled water 4 ml
20 x SSC (Table 11) 12.5 ml
Formamide (VWR) 25 ml
10% Tween 20 (Sigma) 0.5 ml
Yeast RNA (Sigma) 1 ml (stock 50 mg/ml)
Heparin (Sigma) 1 ml (stock 5 mg/ml)
Denhardt’s solution (Sigma) 1 ml (stock 50x)
CHAPS (Sigma) 0.5 ml (stock 10%)
EDTA (Merck) 1ml (stock 0.5 M)
Sections were washed several times in 5x SSC washing solution (500 ml formamide, 250 ml 20x SSC, 10 ml
10% Tween 20, filled up to 1 l with distilled water) followed by 2x SSC washing solution (500 ml formamide,
100 ml 20x SSC, 10 ml 10% Tween 20, filled up to 1 l with distilled water), equilibrated in MAB (100 mM
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Table 11: Recipe for 20x SSC
Component Amount
NaCl (VWR) 175.3 g/l
Sodium citrate (VWR) 88.2 g/l
DEPC 0.1% final
maleic acid (Sigma) pH 7.5, 150 mM NaCl, 0.1% Tween 20), blocked in 1% blocking reagent (Roche) in
MAB for 1 h at RT and incubated with sheep anti-digoxigenin-alkaline phosphatase Fab fragments antibody
(Roche) 1:5000 diluted (2 h, RT). Excessive antibody was removed with MAB. Sections were washed in AP
buffer (100 mM Tris pH 9.5 (Sigma), 50 mM MgCl2 (Merck), 100 mM NaCl, 0.1% Tween 20), overlaid with
BM purple (Roche) for colorimetric detection, incubated for 30 min up to 3 days at 37 ◦C, stopped with 1x
PBS/1 mM EDTA and imaged.
9.7.3 Immunohistochemistry
Sections were washed with 1x PBS/0.3 % Triton R© X-100 and treated with quenching buffer (200 mM
glycine/0.3 % Triton R© X-100, 1x PBS), followed by citrate pH 6 (Dako) diluted in aqua. dest., and blocking
in 10% goat serum for 1 h. Sections were incubated overnight with primary antibody (Table 12). Following
PBS washes, sections were incubated with Alexa Fluor labeled secondary antibody (Invitrogen) for 1 h at
RT (Table 13). Nuclei were counterstained with Hoechst 33342 (Sigma). Digital images were taken.
Table 12: Primary antibodies
Antibody obtained
from
Comments Host species Antigen species Dilution
GFP Rockland 1.02 mg/ml Rabbit 1:500
GFP Invitrogen 2 mg/ml, IgG Rabbit A. victoria 1:400
MHC provided by S.
Hughes
7.3 mg/ml, clone
4A1025
Mouse 1:1460
Neuron-specific
β-III TUBULIN
R&D Systems
R©
Monoclonal IgG2A,
clone TuJ-1
Mouse 1:300
OCT4 MPI-CBG 1.1 mg/ml, M3433 -
6ABD, N-ter.
Rabbit Axolotl 1:5000
PCNA Santa Cruz 200 µg/ml,IgG2A Mouse Rat 1:400
SOX2 MPI-CBG 2.73 mg/ml, M2518
- 4DE8
Rabbit Axolotl 1:500
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Table 13: Secondary antibodies
Antibody obtained
from
Comments Host species Antigen species Dilution
Alexa Fluor R© 488 Invitrogen IgG (H+L) Donkey Rabbit 1:200
Alexa Fluor R© 555 Invitrogen IgM (µ chain) Goat Mouse 1:200
Alexa Fluor R© 555 Invitrogen IgG (H+L) Goat Rabbit 1:200
Alexa Fluor R© 647 Invitrogen IgG (H+L) Donkey Rabbit 1:200
Alexa Fluor R© 647 Invitrogen IgG (H+L) Donkey Rabbit 1:200
9.8 Tissue culture
9.8.1 Passaging of newt A1 myoblasts
Newt A1 myoblasts were cultured on 175 cm2 gelatin (Sigma) coated flasks (NUNC) in 25 ml High serum
- Amphibian MEM (HS-AMEM) (62.5% MEM (Invitrogen), 10% fetal bovine serum (Perbio), 1x peni-
cillin/streptomycin (Gibco), 1x glutamine (Gibco), 1x insulin (Gibco)) at 25 ◦C and 2% CO2. Cells were
passaged once a week whereas one confluent flask was split into three new flasks. After aspirating off the
medium cells were rinsed with 7 ml APBS (0.8x PBS). In order to detach cells 6 ml TE (1x trypsin-EDTA
(Gibco), APBS) was added and the flask was incubated until cells came off. This procedure was monitored
in a microscope. Trypsinization was stopped with 3 ml of HS-AMEM and cells were centrifuged in a 15 ml
tube (Corning) (3 min, 1000 x g). The cell pellet was resuspended by adding 6 ml of fresh HS-AMEM. Cells
were split equally into three gelatin coated flasks, filled with 25 ml HS-AMEM and incubated at 25 ◦C and
2% CO2.
9.8.2 Electroporation of newt A1 myoblasts
Electroporation was carried out according to the providers protocol using Neon R© Transfection System and
the Microporation MP-100 (Peqlab). Briefly, A1 myoblasts were harvested (section 9.8.1) and counted in a
Neubauer chamber. For one electroporation reaction about 1.2x105 cells were resuspended in 12 µl solution
R (Peqlab), mixed with 1.3 µg DNA (pEGFPnuc, pCS2 Oct4 plasmid was a kind gift from J. Brickman),
morpholino up to 1 mM final and transfered to a 10 µl Gold tip (Peqlab). The pipette with the cells in the
tip was placed into the microporator pipette station (Peqlab) filled with 1x Steinberg’s and electroporated
(600 V, 35 ms, 3 pulses). After the pulse cells were transfered to a gelatine coated HS-AMEM filled Lab-
TekTM Chamber SlideTM System (Nunc) and incubated at 25 ◦C and 2% CO2. One day later HS-AMEM
was replaced by fresh medium and cells were further incubated at 25 ◦C and 2% CO2.
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9.8.3 Human cell culture
Culturing of cells was performed by the collaborators from the group of H. Scho¨ler. Their protocol is
summarized briefly here. Primary human skin fibroblasts used here were isolated from two Caucasian women
- 48-year-old (hFib #1) and 33-year-old (hFib #2) - and cultivated for several passages in fibroblast medium,
composed of DMEM high glucose, supplemented with 10% fetal bovine serum, 1% sodium pyruvate, 2
mM L-glutamine and penicillin/streptomycin (all PAA), on gelatin-coated culture dishes until infection.
Human ES cells and iPS cells were cultured on mitomycin C-treated CF1 mouse feeder layers (Millipore) in
human ES cell medium, composed of KnockoutTM DMEM (Invitrogen), 20% KnockoutTM serum replacement
(Invitrogen), 1% nonessential amino acids (PAA), 0.10 mM β-mercaptoethanol (PAA), 2 mM L-glutamine and
penicillin/streptomycin, supplemented with 5 ng/ml human basic fibroblast growth factor (Peprotech), and
passaged as described previously (Huangfu et al., 2008a). Mouse embryonic fibroblasts (MEF) were isolated
from 13.5-dpc OG2 embryos (Yeom et al., 1996) and cultured in fibroblast medium as described above. Mouse
ES cells and iPS cells were cultured on irradiated MEF in mouse ES cell medium, composed of KnockoutTM
DMEM (Invitrogen), 20% KnockoutTM serum replacement (Invitrogen), 1% nonessential amino acids (PAA),
0.10 mM β-mercaptoethanol, 2 mM L-glutamine and penicillin/streptomycin, supplemented with leukemia
inhibitory factor.
9.8.4 Induction of pluripotent stem cells
This experiment was performed by our collaborators from the group of H. Scho¨ler. Their protocol is sum-
marized briefly here.
The moloney-based (pMXs) retroviral vectors with the cDNAs for either human Oct4, mouse Oct4, xenopus
Pou91, zebrafish Pou2, medaka Pou2, axolotl Oct4, axolotl Pou2 or axolotl Sox2, as well as human and mouse
Sox2, Klf4, and c-Myc were cotransfected with packaging helper plasmids into human embryonic kidney 293T
cells using Fugene 6 transfection reagent (Roche) to produce vesicular stomatitis virus G proteinpseudotyped
virus as previously described (Huangfu et al., 2008b; Takahashi et al., 2007). Viral supernatants were collected
48 h later, filtered, and used directly for infection. Human fibroblasts were transfered to gelatin-coated 6-well
plates at a density of 50000 cells per well one day before the first infection. Fibroblasts were incubated
twice with viral supernatants containing combinations of equal amounts of each virus and supplemented with
6 µg/ml protamine sulfate (Sigma Aldrich) for 24 h. One day after the second infection, fibroblasts were
reseeded at a density of 25000 or 50000 cells per well on gelatin-coated 6-well plates in human fibroblast
medium. One day later, the medium was exchanged to human ES cell medium supplemented with 1 mM
valproic acid (Sigma Aldrich). Valproic acid was withdrawn once human ES cell-like colonies were visible.
iPS cell colonies were isolated within three to seven weeks of infection and were replated and maintained on
CF1 mouse embryonic fibroblast (MEF) feeder cells (Millipore) in human ES cell medium.
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The axolotl Oct4 human iPS cell reprogramming experiment was repeated twice using two different fibroblast
cell lines (marked as human Fibroblast #1 hFib #1 and human Fibroblast #2 hFib #2) each time. The
axolotl Pou2 human iPS cell reprogramming experiment was carried out once using both hFib #1 and hFib
#2 to demonstrate its reproducibility. Mouse iPS cells using all different Pou factors were generated as
previously described (Takahashi and Yamanaka, 2006). Two independent experiments using duplicates for
each Pou factor were performed. The percentage of mouse reprogrammed GFP-positive cells was determined
using a FACSAria cell sorter (BD Bioscience) two weeks after infection. After sorting, GFP-positive cells
were plated on irradiated MEF from which single cell colonies were picked and expanded.
9.8.5 Characterization of induced pluripotent stem cells
These experiments were performed by our collaborators from the group of H. Scho¨ler. Alkaline phosphatase
staining, immunohistochemical staining for NANOG, OCT4, SSEA1 and SSEA4, quantitative real-time
(qRT)-PCR, genotyping, in vivo teratoma formation, hematoxylin - eosin staining and bisulfite sequenc-
ing were carried out as already described (Kim et al., 2009a,b, 2008). Clonal iPS cell lines were characterized
at passage 5.
9.8.6 In vitro differentiation of human induced pluripotent stem cells
This experiment was performed by our collaborators from the group of H. Scho¨ler. Their protocol is sum-
marized briefly here.
Embryoid bodies were generated from human iPS cells using the hanging-drop method in MEF-conditioned
medium, supplemented with 10 µM ROCK inhibitor Y27632 (Ascent Scientific), for 5 days (1000 cells/30
µl drop). Embryoid bodies were plated on gelatin-coated plates and cultured for 14 days in different me-
dia. The following media were used to direct differentiation into specific lineages. Endodermal lineage:
DMEM low glucose, 10% FCS, and 2 mM L-glutamine and penicillin/streptomycin. Mesodermal lineage:
IMDM, 20% FCS, 2 mM L-glutamine and penicillin/streptomycin, 1% nonessential amino acids, 0.05 mM
β-mercaptoethanol, and 0.004% ALPHA-thioglycerol (Sigma Aldrich). Ectodermal lineage: N2B27 medium
without retinoic acid, supplemented with 5 µM SB431542 activin A receptor inhibitor (Sigma Aldrich).
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